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Abstract
Diagnostic methods to effectively image dense breast tissue (DBT) can pose challenges
for breast cancer screening. While conventional mammography is the gold standard for
breast cancer screening, this technique has a low sensitivity to DBT and can miss about
78% of cancers in DBT, but magnetic resonance imaging (MRI) has a high sensitivity for
imaging DBT, and produces a smaller number of false positives. The purpose of this
study was to determine the extent to which conventional mammograms can miss breast
cancer in women with DBT and to determine if an adjunct method of imaging DBT
might detect breast cancers that are missed by mammography alone. Quantitative data
were collected from a sample of 300 randomly selected participants using surveys. SPSS
statistical software was used to analyze the data with the factor analysis method.
Qualitative data were collected by telephone interviews from 10 women who were
patients of a breast cancer center. NVivo software was used to analyze the data with the
thematic analysis method. All analyses were guided by theoretical framework of von
Bertalanffy’s general systems theory, Miller’s living systems theory, and the theory of
intelligent medical diagnosis. Key results determined that a significant number of women
with DBT had breast cancer that was undetected by mammograms; results also showed
that women with DBT can benefit from breast cancer screening by adding an adjunct
screening method (e.g., MRI). This study may contribute to social change by making the
breast cancer screening community aware of the potential benefit of adding MRI as an
adjunct to conventional screening so that more breast cancers are detected in the early
stages of the disease.
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Chapter 1: Introduction to the Study
Introduction
In 2010, the last year for which the Centers for Disease Control and Prevention
(CDC) has figures, the leading cause of death in women was heart disease (23.5%),
followed closely by all cancers at 22.1% (cdc.gov). The National Cancer Institute (NCI)
predicted that in 2013, over 876,000 women would be diagnosed with breast cancer in the
United States (2010). Of that number, it was expected that nearly 40,000 would die from
the disease. There are risk factors for heart disease, and lifestyle modifications may
ameliorate the time of onset or severity of the disease, but estrogen and progesterone in
women are the elements that fuel breast cancer, so gender itself is the major risk factor.
Early detection of breast cancer is currently the single most effective way to
modify the course of the disease, and treatment may then be made through surgery,
radiology, chemotherapy—or a combination (ACS, 2013). . Cancer registries, such as
the American Cancer Society (ACS) and the American College of Radiology (ACR),
recommend mammography as the diagnostic imaging tool for screening women for
breast cancer (ACS, 2013). Conventional mammography will usually detect cancers, but
it has a lower sensitivity to dense breast tissue (DBT) and can miss breast cancers in that
kind of tissue.
Breast density is measured by a tool called Breast Imaging Reporting and Data
System (BI-RADS). When conventional mammographic techniques are used to image
breasts with DBT, both fat and glandular tissues are visualized as white areas, making
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differentiation between the two difficult (Boyd et al., 2010). Breast cancer can be
camouflaged in DBT because dense or glandular tissues have densities that are similar to
surrounding tissues. If breast density is high, there is a greater amount of glandular
tissues than fatty tissues; if breast density is low, there is a higher amount of fat than
glandular tissues. In DBT, conventional mammograms cannot effectively detect cancer in
those dense areas of breast tissue (ACR, 2013).
In this study, I explored the effectiveness of ultrasonography and magnetic
resonance imaging (MRI) as adjuncts to mammography screening DBT for breast cancer.
The sensitivity of these imaging options were compared and contrasted to evaluate
whether ultrasonography or MRI should be adjuncts in conventional mammography for
breast cancer screening. This investigation was important because the outcome could
build upon research that suggests that an additional method is needed to more accurately
screen DBT and potentially save lives of women whose breast cancers might otherwise
go undetected through conventional imaging (ACR, 2013).
Chapter 1 is a presentation of information about the practice of mammography
alone to screen for breast cancer and includes a discussion of the two additional imaging
options, ultrasonography and MRI, to determine their efficacy. The chapter also includes
the nature of the study, the purpose of the study, the conceptual framework, the
hypotheses to support the research statement, the assumptions, scope and delimitations,
limitations, and significance of the study.
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Background
It was not until prominent women such as Betty Ford and Nancy Reagan went
public with their diagnoses and treatment for breast cancer in the 1980s that widespread
attention was paid to the disease (Braun, 2003). Nancy Brinker, who established Susan G.
Komen for the Cure in 1982 (named for Brinker’s sister who died from the disease at the
age of 36) helped to bring the subject of breast cancer to the forefront (Harrison, 2013).
The wider public became then aware of the disease, its impact, and its complications
(Harrison, 2013). The openness about the issue of breast cancer in the 1980s resulted in
increased emphasis on early detection through breast self-examinations and scheduling
mammograms and having clinical breast examinations (Harrison, 2013).
Although mammography remains the standard of screening for breast cancer, the
efficacy and sensitivity of mammographic techniques for imaging DBT are concerns
(Drukteinis et al., 2013). In the United States, 40% of all women who had breast
screening with mammography had DBT (NCI, 2012). At the New York Cancer Center in
2009, 500 women, aged 40-79 years, who had mammograms were found to have DBT in
the following proportions: 74% in their 40s, 54% in their 50s, 42% in their 60s, and 31%
in their 70s (Nelson et al., 2009).
DBT can mask breast tissue that is cancerous and aggressive, causing these
aggressive breast cancers to go undetected before they are treated (Yaghjayn et al., 2011).
Adjunct imaging techniques, such as ultrasonography and MRI, are recommended by the
ACR, CDC and NCI to image DBT, but MRI is recommended only for women with a
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high risk for breast cancer (ACR, 2012). The high-risk group of women with breast
cancer is in the group with known BRCA (breast cancer) mutation carriers and firstdegree relatives who are carriers of the breast cancer gene (Berg, 2009). Other women
who do not fit into this category, such as those with DBT, may not have the option of
having an MRI tool as a screening mechanism (Berg, 2009). One of the many advantages
of MRI for screening women with DBT is having a more accurate and faster diagnosis
and treatment plan if there are cancerous lesions in the DBT (Berg, 2009).
Ultrasonography also complements conventional mammography for dense breast
screening, but this imaging modality has several setbacks: It is dependent on the skills of
the operator and there is a shortage of operators (ACR, 2014). The technique can also fail
to identify small lesions and provides more false positive findings than conventional
mammograms (Youk & Kim, 2010). Although ultrasonography and MRI are used for
breast imaging, MRI is typically used only for the high-risk population, not for routine
breast screening of DBT.
Problem Statement
The use of conventional mammography for breast cancer screening can miss
breast cancer in DBT (ACR, 2014; Susan G. Komen, 2013). With the probability of
breast cancer occurrence at one in eight women, there is a need for an effective screening
process for those with DBT (ACS, 2013; NCI, 2012), since early detection provides the
potential for saving more lives. In 2013, Harvard Health Publications published the
results of a 2004 study of 171 women in the United States (Harvard Health Publications
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(2013). Conventional mammography, ultrasonography, and MRI imaging were all used,
and the results showed that MRI was the most accurate at finding breast cancer; biopsies
confirmed that MRI found 100% of breast cancer while conventional mammography and
ultrasonography found 16% of breast cancer.
Even though mammography alone for breast screening can miss tumors and
cancers that are masked by glandular breast tissues—because X-rays have a low
sensitivity to glandular tissues—organizations such as the NCI and ACR do not currently
recommend MRI to screen for DBT (Berg, 2009). Ultrasonography can detect cancers
and tumors in glandular tissues, but studies have shown that its use for imaging DBT has
led to detection of small benign tumors and a greater number of false positives—and thus
an increased breast biopsy rate—than conventional mammography (Berg, 2009).
MRI has a high sensitivity to glandular breast tissue, and because of its sensitivity
to DBT and its specificity, it enables clearer imaging of DBT for breast cancer detection
(Karellas and Vedantham, 2008). The way MRI images breast tissue is based on physics.
Scientists suggest that normal breast tissues and malignant breast tissues must be
separated on acquisition of breast images (Hendricks, 2007). Scientists supported their
argument on the longitudinal relaxation times (T1), the transverse relaxation times (T2),
and the spin densities of the hydrogen protons that are abundant in water molecules in the
human body (Hendricks, 2007). Cancerous tissues were found to have higher T1 and T2
values than normal tissues (Hendricks, 2007). Because MRI can distinguish between
normal and cancerous breast tissues, its sensitivity for breast imaging is embraced by the
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breast imaging community (Hendricks, 2007). However, MRI alone can lead to false
positives. But if it is used with mammography for breast screening in DBT, the gap can
be minimized, and women with DBT could have early detection of breast cancer,
followed by early treatment.
Purpose of the Study
The purpose of this study was to determine to what extent conventional
mammograms can miss breast cancer in women with DBT and to determine if an adjunct
method of imaging DBT might detect breast cancers missed by mammography alone.
The paradigm was the mixed-methods research model, with the quantitative phase done
first to test the theory that conventional mammograms can miss cancers in DBT. The
qualitative approach was then used to obtain data provide responses based on the lived
experiences of women with DBT. The mixed-method approach was used to broaden
understandings of the research topic by integrating the quantitative and qualitative
research strands (Creswell, 2009).
Research Questions
The following two research questions guided this study:
Research Question 1 (quantitative): Should MRI be used for screening women
with DBT as an adjunct to conventional mammography?
H0: MRI technique for screening women with DBT should be used as an
adjunct to conventional mammography.
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H1: MRI technique for screening women with DBT should not be used as an
adjunct to conventional mammography.
Research Question 2 (qqualitative): What are the lived experiences of women
with breast cancer in DBT prior to and after the breast cancer diagnosis?
Subquestion 1: What circumstances prompted the need to screen for breast
cancer?
Subquestion 2: How were the lives of women with a DBT cancer diagnosis
impacted from the initial breast cancer screening to the final breast cancer
diagnosis?
Subquestion 3: How does having DBT with a cancer diagnosis affect the lives
of women with the disease?
Subquestion 4: How might the addition of an adjunct imaging method, MRI,
to the existing method help to bring a deeper understanding and a definite
diagnosis of cancer in DBT?
Conceptual Framework
The theoretical framework supporting this study consisted of von Bertalanffy’s
(1968) general systems theory, Miller’s (1978) living systems theory, and the theory of
intelligent medical diagnosis (Jones, Lowe, & Harrison 2002). Von Bertalanffy argued
that subsystems interrelate and depend on each other for the creation, mutation, process,
and survival of the system. In the body, subsystems support each other in order for the
body to survive. When these subsystems are not functioning correctly, other subsystems
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may fail, causing the body to die. If breast cancer is not diagnosed and treated in the early
stages, it can metastasize and spread to other parts of the body, causing other subsystems
to fail, resulting in death. When cancer is present, subsystems cannot function
holistically.
Subsystems within the human body must work together for the individual to be
healthy. If MRI or ultrasonography is used in addition to conventional mammogram, a
diagnosis of cancer can be made at the screening phase; intervention and treatment could
follow. Treatment could commence immediately, which can bring social change at the
individual and community levels.
Miller’s (1978) living systems theory presents the supra system of a component
and the need for all subsystems within the supra system to be integrated and to adjust
within their environments for the survival of the supra system (Miller, 1978). Similarly,
all subsystems within the human body are dependent on each other for the survival of the
human. When there are untreated diseases in the human supra system, then the supra
system will fail. In the case of breast cancer screening in DBT, if the cancer is detected
early, it can be treated early? And thus allow subsystems to be integrated and to adjust for
human survival.
This study was also informed by the theory of intelligent medical diagnosis (Jones
et al., 2002). It permits the use of all knowledge and information that is available from a
general and ambiguous perspective in service of an outcome that offers new insights
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(Jones et al., 2002). As in this study, early detection of breast cancer in DBT can lead to
early treatment for the disease.
General systems theory and living systems theory have a direct relationship to the
study. All systems within the human facilitate the proper function of the body, but when
breast cancer is not detected, this can cause disruption in the harmonious flow and
integration of subsystems, which will cause the holistic supra system to fail. In the life
process, life can end if breast cancer is undetected or if it is detected too late. If breast
cancer is not detected in DBT, then subsystems cannot adjust to compensate for
malfunction, a fractured system results, which can lead to a breakdown and
nonregeneration of the holistic system (Miller, 1978; von Bertalanffy, 1968). In addition,
the theory of intelligent medical diagnosis has a direct relationship with the study, as it
allows for vague evidence, when analyzed, contributing to an understanding of the topic.
Nature of the Study
This study used mixed methods with a sequential explanatory strategy (Creswell,
2009). I chose this methodology because health care issues are complex, and neither the
quantitative nor the qualitative approach alone has the scope to explore, synthesize,
analyze, or provide support to the research hypothesis that MRI can be used as an adjunct
to conventional mammography to screen DBT for breast cancer (Creswell, 2009).
The quantitative method was used in the first phase to guide the study, to explore,
test, explain, and make predictions about the research phenomenon (Simon & Goes,
2013). The qualitative strand was used in the second phase and built on the quantitative
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data to amplify the topic (Creswell, 2009). The results of both paradigms were integrated
to present the findings (Creswell, 2009; Simon & Goes, 2013).
Quantitative data were used to test the hypothesis and to learn whether an adjunct
imaging method was needed for DBT because conventional mammography has a low
sensitivity to glandular tissues and can miss cancer in glandular breast tissue. Statistical
techniques were used to determine if the hypothesis was accepted or rejected. This
research method also includes a narrow angle to show the effectiveness of conventional
mammography, sonograms, and MRI to image DBT. Sonograms and MRI techniques
were reviewed to show which imaging technique is effective or has a high sensitivity to
DBT. Data for the quantitative portion were collected from national registries, such as the
CDC, NCI, and ACR. Data were analyzed to determine if the statistical connection
showed a need for an adjunct imaging method to image DBT for this specific population
of women.
In Phase 2, I asked 20 women with DBT who had conventional mammograms,
sonograms, and MRI for breast cancer screening to respond to a questionnaire. An e-mail
explained the purpose of the study and the intended use of the results, including
providing them to participants as an incentive to participate. The women surveyed for the
study were selected from a small suburb in California. I will discuss the details of data
collection in Chapter 3; synthesis and analysis appear in Chapter 4.
Definitions of Terms
The following terms are defined for the purpose of this study:
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BRCA: Term used to describe breast cancer susceptibility genes. A BRCA gene
test can be done by a blood test to determine if one is a carrier of the inherited BRCA
gene (Mayo Clinic, 2013).
BI-RADS: Term used to quantitatively express densities of breast tissue (ACR,
2013).
Conventional mammography: A diagnostic examination that used radiation to
image breast tissue and to screen for breast cancer (Radiologyinfo.org, 2013).
Dense breast tissue: Glandular breast tissue (Susan G. Komen, 2013).
False positive: General findings that are positive for a broad spectrum of a
specific disease that cannot be determined as malignant or benign without further
investigation (Elmore et al., 2013).
MRI: Magnetic resonance imaging is a diagnostic imaging method that does not
use ionizing radiation, but uses a magnetic field, hydrogen protons in the body,
radiofrequency pulses, and a powerful computer to produce cross sectional images of the
body (WebMD, 2013).
Ultrasonography: A process that uses sound waves to reveal images of bodily
tissue (WebMD, 2013).
Assumptions
This study was based on several assumptions:
1. MRI can be used to image breast tissue, but usually only for high-risk
patients. It also increases breast-screening costs.
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2. Some health care insurance providers oppose MRI for screening for DBT
because of the cost of the test.
3. MRI is not used to image DBT for breast cancer screening because of cost.
4. Not all states require radiologists and physicians to notify women if there is a
finding of DBT.
5. Some physicians believe that MRI produces false positive results and might
cause patients with DBT to experience increased anxiety.
6. An MRI can be uncomfortable because of claustrophobia or discomfort during
the long testing procedure.
7. Only physicians from California, Connecticut, New York, Texas, and Virginia
are mandated to notify patients of the results of conventional mammography
for DBT results (Advance for Imaging & Radiation Oncology, 2013).
Scope and Delimitations
The scope of the study was to learn the specificity of ultrasonography and MRI in
relation to the recommended method of conventional mammography. I collected data
from cancer registries at the ACS, ACR, and CDC and analyzed them to determine if
there is a gap in imaging modalities when imaging DBT in breast cancer screening.
SurveyMonkey was used to collect data from an e-mailed Internet interview (Creswell,
2009). SurveyMonkey is a web-based data collection tool that has been used since 1999,
has been field tested, and has proven to be effective. To establish validity of
SurveyMonkey, I assessed the tool for four criteria: credibility, transferability,
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dependability, and conformability (Creswell, 2009, p. 149; Simon & Goes, 2013, p. 1;
Trochim & Donnelly, 2007). I checked reliability for the qualitative data collection using
SurveyMonkey using member checking (Simon & Goes, 2013). Data provided
information about the timeline of the dense breast diagnosis and other imaging options
that were provided. The diagnosis for each imaging modality for DBT was analyzed,
compared, and contrasted.
Qualitative data were collected over 2 weeks from women in a specific region
who had been diagnosed with DBT and who responded to open-ended questions to gain a
detailed response to their experiences with alternative methods of screening. They were
asked to describe (a) the imaging method used for breast screening, (b) cancer diagnosis
or not, (c) whether additional imaging techniques were used to further test if the result of
breast cancer screening was abnormal or inconclusive because of DBT, and (d) when
treatment commenced after a cancer diagnosis or prognosis of the disease.
Limitations
The following were considerations relative to the outcomes:
1. The study might have been hindered by time and cost constraints, as both
numeric and text data were collected. Since the study is complete, would you
know the answer to this?
2. Weight of the methodology paradigm might determine if the research would
depend more on quantitative or qualitative data. Since the study is complete,
does this issue remain?
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3. What would be the right point in data collection to mix results of collection,
analysis, or interpretation? (Creswell, 2009). It is not clear how this would be
a weakness.
4. The number of women with DBT in the region did not provide enough
participants for the study.
5. Some women with DBT choose not have an MRI and have a sonogram
instead. This decision may yield a smaller sample, which might not be
generalizable or applicable to a larger population.
6. MRI can produce false positive results, a diagnosis that could lead to anxiety.
Significance of the Study
One in eight women in the United States will die from breast cancer (NCI, 2012).
Although the United States has the best equipment for diagnosis, highly qualified
radiologists, physicians, hospitals, and medical clinics, breast cancer can be missed in
DBT with the use of only conventional mammography for breast cancer screening (Boyd
et al., 2007). However, MRI is a newer imaging modality for breast cancer diagnosis, and
many physicians do not trust the results of this advanced technique because of the
number of false positive findings. MRI, however, has a higher sensitivity for breast
cancer detection in DBT, and the use of this technique can complement conventional
mammography for breast cancer evaluation.
The literature reveals that conventional mammography remains the only method
for breast cancer screening, and conventional mammograms have a low sensitivity to
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glandular tissue and can miss cancer in DBT (Boyd et al., 2007/2010). There is a need for
an adjunct imaging method that has a higher sensitivity to glandular tissues (Berg, 2009).
Ultrasonography has been used to image DBT, but the false positives remain very high
(Berg, et al. 2008; Padilla et al. 2013). False positive results from DBT using
ultrasonography have resulted in a higher number of breast biopsies that were benign
(Berg, et al, 2008; Padilla et al. 2013). MRI has produced accurate results for dense
breast imaging but currently has been used only for high-risk breast cancer patients.
The current trend in breast screening is conventional mammograms, and this
technique is used nationally to screen women for breast cancer. (ACS, 2013). In
California, Connecticut, New York, Texas, and Virginia, radiologists and physicians are
required to inform patients if they have DBT (ADVANCE for Imaging & Radiation
Oncology, 2013). DBT is measured using the six-category system initiated by the ACR
called BIRADS. There are six levels of breast density measurements: 0, <10%, 10-25%,
26-50%, 51-75%, and >75% (Yaffe, 2008). Findings of DBT must be disclosed to the
patient. Usually, the physician recommends that additional imaging is needed to see
inside the DBT. At this stage, though, it is the patient’s decision to explore additional
options for dense breast imaging. If the patient is not familiar with options for dense
breast imaging and physicians believe that a sonogram is a better choice because of the
cost factor, then the patient may follow that recommendation. MRI, however, has
produced extremely stable results for dense breast imaging, and when used with
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conventional mammogram, it can produce accurate results for breast cancer diagnosis in
DBT (Berg, 2009).
Summary
Mammography is the standard tool used for breast cancer screening, and although
it is effective for routine mammography, it has a low sensitivity for DBT and can miss
some cancers (Giuliano & Giuliano, 2012). Ultrasonography is used as an adjunct to
conventional mammography, but this method yields more false positives for breast cancer
anomalies than conventional mammography. Imaging of DBT utilizing MRI has yielded
accurate findings for breast cancer among the group of women with DBT and produces a
lower number of false positive cases. MRI has a higher sensitivity for imaging DBT
because its unique characteristics enable it to reveal the matter inside dense tissue. Added
to conventional mammography, MRI will result in more accurate diagnoses of breast
cancer.
Chapter 2 is a review of professional and peer-reviewed literature on breast cancer
screening, including comparisons among conventional mammography, ultrasonography,
MRI, and their application and results. In Chapter 3 the methodology that was used to
conduct the study is covered. Chapter 4 presented the results of the study and Chapter 5
presented an interpretation of the study, limiting factors, recommendations for future
research and how the results of this study might effect social change social.
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Chapter 2: Literature Review
Introduction
The purpose of this study was to determine to what extent conventional
mammograms can miss breast cancer in women with DBT and to determine if an adjunct
method of imaging DBT might detect breast cancers missed by mammography alone.
The purpose of this chapter was to learn what research has shown about the sensitivity of
MRI and ultrasonography to cancer in DBT. Although conventional mammography is
effective for routine breast cancer screening, it has a low sensitivity to DBT and can
therefore miss cancers in these tissues (ACR, 2012); in the United States, the figure is
about 20%.
The literature review consists of four sections:
1. Section 1presents peer-reviewed material on an historical overview of options
for dense breast tissue imaging.
2. Section 2 is a discussion of the theoretical foundation of the study: general
systems theory, living systems theories, and the theory of intelligent medical
diagnosis. It draws a parallel to the hypothesis that an adjunct imaging option
can be of benefit in imaging dense breast tissue.
3. Section 3 includes arguments that agree or disagree with the premise of the
study.
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4. Section 4 explores peer-reviewed material on the sensitivity or lack of
sensitivity of conventional mammography, ultrasonography, and MRI
imaging methods for cancer detection in glandular breast tissues.
Literature Search Strategy
Most sources in this chapter are from the American College of Radiology (ACR),
the American Cancer Society (ACS), the National Cancer Institute (NCI), and the Susan
G. Komen Foundation. Additional sources were obtained through the following
databases: EBSCO, MEDLINE, CINAHL, PubMed, Science Direct,Cochrane Database
of Systemic Reviews, and ProQuest Dissertations & Theses. The following keywords
used to search the literature: DBT, imaging options, MRI as a screening tool,
uultrasonography as a glandular tissue screening tool, adjunct imaging screening tools,
sensitivity of conventional mammography to screen for DBT, sensitivity of
ultrasonography to screen for DBT, dense breast measurement, BI-RADS, general
systems theory, and living systems theory.
Theoretical Foundation
System theory asserts that elements within an entire system are dependent upon
each other for the system to function properly (von Bertalanffy, 1968). When a
subsystem within the general system cannot function or fails, this can cause the holistic
system to stop its functionality (Miller, 1974; von Bertalanffy, 1968). Thus, since the
failure of one system in the human body can cause the organism to fail, this theory has
application to the study. The living systems theory (LST) explains the concept of the
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living organism and the integration of its parts for sustainability, while general systems
theory (GST) explains adaptation of networks within a complex system. These theories
are relevant to this study because DBT is part of the holistic human body, and if cancer is
found and treated, then the human body can achieve sustainability. Cancer researchers
apply GST and LST to their work because these theories can explain that if a disease is
detected early, it can be treated early and prevent systemic morbidity (Rosenfeld &
Kaptanovic, 2008). Additionally, this study is guided by the theory of intelligent medical
diagnosis (Jones et al., 2002). The theory of intelligent medical diagnosis is to understand
the disrupted homeostasis of all aspects of a particular phenomenon and combine a
variety of options for a robust solution (Jones et al., 2002; Koutsojannis &
Hatzilygeroudis, 2006). The theory of intelligent medical diagnosis is relevant to the
study because cancer in DBT can interrupt the normal function of the human body, and if
not found in the early stages, can disrupt the normal function of the body.
The ACS promotes screening for early detection of breast cancer by advising
those who are at a high risk for breast cancer to seek MRI breast screening, as
conventional mammography has limitations for detecting cancer in DBT (2013). If there
is early detection of the disease, early treatment options can be pursued. As suggested by
the social change theories of von Bertalanffy and Miller, holistic systems are comprised
of multiple subsystems that integrate to form the whole system and that the system may
die if one subsystem fails (von Bertalanffy, 1968). Similarly, the human body may die if
breast cancer is undetected and spreads to other organs. Additionally, Miller (1978) stated
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that if a subsystem within the general systems fails, but is repaired, then the general
system could continue to function.
GST application in nursing practice (Glennister, 2011) showed the importance of
sub disciplines within the holistic nursing practice and its position in the community.
Glennister, (2011), and stated that because nursing covers a multitude of subsystems for
its functionality, a failure of one subsystem can cause the holistic system to cease to
function. The application of GST is well demonstrated in system thinkers such as
Henning (2011), who argued that for human beings to achieve their goals, a human
network support must be available. However, if there is a failed mental health subsystem
in the support network, the goal will not be achieved and the whole system will fail.
LST application to combat models for the army (Crawford & Naval Post Graduate
School, 1981), articulated the need to integrate more organization into the existing
framework. The author stated that the combat model is dependent on the existence and
integration of all levels of personnel, peer and subsystems, for a robust combat model.
Riss (2012) connected LST with migration and stated that migration occurs because of
the malfunction of the status quo from which interconnectivity arises. Riss (2012) also
stated that migration causes reproducibility, which can create a new living system in a
different environment. Similarly, GST and LST are frameworks that helped to guide and
build this study.
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Dense Breast Tissue Imaging Options
The ACR (2012) reported that about 80% of women have DBT. Conventional
mammography has been the sole method to screen women for breast cancer; however,
this method can miss cancers are in DBT (Berg, 2009). Imaging methods such as
ultrasound and MRI have proven to detect cancers in DBT, but these methods are not
used for routine screening for the dense breast population (ACS, 2012; ACR, 2012; Berg,
2011).
Conventional Mammography
Although breast X-ray examinations were done prior to 1969, it was not until
1969 that that dedicated machines were developed for breast cancer screening (ACS,
2012). Seven years later, mammography became the customary method to screen for
breast cancer (ACS, 2012). In addition, the Mammography Quality Standards Act
(MQSA) was passed by Congress in 1992, an act that mandated that operators of
mammography machines be well trained to operate the equipment, the machines
regularly updated, and results of tests communicated to patients (FDA, 2012).
Mammography has been the standard for breast cancer screening since 1969 (ACS,
2012). If anomalies were seen on breast screening radiographs, diagnostic mammograms
were then done on concentrated areas of the breast, (ACS, 2012).
There was one major setback for diagnostic mammograms with a breast cancer
diagnosis. Although the FDA required minimizing the radiation dose, an additional
mammogram was sometimes necessary, increasing the dose to the patient (ACS, 2012).

22

Other setbacks for mammograms and diagnostic mammograms were accuracy of imaging
equipment, expertise of the interpretation radiologist, and the expertise of the
technologist. However, mammography was the sole imaging method for breast cancer
screening despite an increased radiation dose to the patient, and any abnormal breast
finding would result in a repeat mammogram (Breast Cancer.Org, 2012). The ACS
reported that in 1969 when breast screening began, abnormal mammograms were not
attributed to DBT, and abnormal breast tissue findings were followed by additional
mammograms (2012). This practice increased the radiation load and still could not
provide accurate images in DBT.
The ACS recognizes that DBT is not an abnormal finding for breast screening,
especially in asymptomatic women, younger women, and older women, but there is no
consensus on what other imaging examinations should be used in addition to a
conventional mammogram (2012). DBT is problematic because mammography has a low
sensitivity to dense tissues and can miss cancers in them (Berg, 2011). Cancers can hide
and grow in DBT, and if this anomaly is not found using other imaging techniques with
higher sensitivity to DBT, there is a high probability that breast cancer can be missed,
remain untreated, metastasize, and spread to other parts of the body (Berg, 2011).
The ACR recommends that women should have a mammogram beginning at age
40 for breast cancer detection, but does not have recommendations for screening for DBT
(2012), even though in the United States, 40% of women who had mammograms have
DBT (Senatorsimitian, 2012). In the general population, 10% of women have DBT while
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80% have a mixture of fatty and DBT (ACR, 2012). The Mayo Clinic (2013) reported in
a recent study that 75% of breast cancers in DBT are undetected by mammographic
screening. Dense breast tissues are very bright in mammograms, and abnormalities in
DBT appear bright as well, which makes diagnosis difficult. Many women have DBT:
those who are younger, who have low hormone levels, who have borne children, are in
menopause, or who are pregnant (ACS, 2012). Although a radiologist may tell women
they have DBT, often there is no recommendation for what the women should do next.
The CDC recommends screening for breast cancer in three ways: a mammogram,
a clinical breast exam (CBE), and a breast self-exam (2012). However, the CDC says
these screening methods must be discussed with a physician and does not recommend
other imaging options. The CDC (2012) reported that each year 350,000 people will have
a cancer diagnosis, and 100,000 will die from the cancer. Healthy People 2020 observed
that although the target rate for breast cancer screening is 81%, breast cancer screening is
only 72.4%. Women are not being screened for breast cancer at recommended rates,
which makes it difficult to know about the population with DBT.
Ultrasonography for Imaging Dense Breast Tissue
When ultrasound techniques were introduced for breast imaging in 1951, it was
embraced by the medical community because the technique does not use radiation for
imaging. Rather it differentiates between cysts and masses for surgical invasive breast
procedures (Medscape, 2012). In ultrasound imaging, a transducer sends out high
frequency sound waves and listens for returning echoes that are sprung back from
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internal organs such as blood vessels, fluids, and tissues. These echoes are measured by a
specialized computer for a real-time image.
While ultrasound techniques evaluate obvious anomalies such as lumps, breast
pain, postsurgical breast tissue, and breasts that have had an abnormal mammogram
finding, ultrasonic techniques are limited for breast cancer screening. Factors such as
operator expertise and quality of equipment used for using ultrasound to scan breasts for
breast cancer screening are major considerations. Sabih (2013) stated that using handheld transducers for breast cancer screening and even basic breast screening is inadequate
for breast imaging. The American College of Radiology Imaging Network (ACRIN)
reported that breast screening can only be accurately done if ultrasound machines are
automated; since automated ultrasound machines have higher resolution that produces
more accurate findings because of its inherent near-field resolution (Sabih, 2013).
In a 2013 publication by the ACRIN, Berg stated that using sonography for DBT
provided results that showed small non palpable tumors in DBT that were not seen on
conventional mammograms. Berg further stated the benefit of sonography use to detect
anomalies in DBT was not 100% clear. Finding small non palpable tumors during
mammogram might create bias in the sonography findings. A larger study provided
results from data published by Kelly et al. (2010) in which 4,419 women were scanned
using the automated whole breast ultrasound (AWBU). Results from this study showed
that using the AWBU yielded significant cancer detection in DBT when this technique
was used in conjunction with mammography, but it did not clearly define if AWBU can
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be used solely for DBT screening. Berg (2008) had a similar view that ultrasound to
image DBT has setbacks, including inconsistent proficiency of the operators and lack of
standardized protocols.
The ACR implemented a standardized process called Breast Imaging Reporting
and Data Systems (BI-RADS), a classification used as evaluation criteria (Nothacker,
2009). The BI-RADS standard process yielded occult tumors and increased the number
of unnecessary biopsies. Berg (2008) stated that when ultrasound was added for dense
breast screening with mammography, cancer identification increased to 1.1 to 7.2 per
1,000 high risk women, but Berg concluded that ultrasound use increases the number of
false positives. The ACS (2012) recommends that high-risk women have additional
imaging for breast cancer but does not recommend ultrasound for women with DBT.
However, the ACS reported that in addition to conventional mammography, ultrasound
techniques can produce benefits if there is a DBT finding on a screening mammogram.
They concluded, however, that the quality of an ultrasound of DBT depends on the skill
of the operator.
The NCI (2012) stated that ultrasound can detect breast cancer in 3.7 cases per
1,000 women who are screened after the second and third annual breast screen. However,
the NCI suggested that there are a high number of false positive and false negative
findings using this technique and does not recommend it be used to screen for breast
cancer (NCI, 2012). The Susan G. Komen foundation reported in 2013 that physicians do
not normally use breast density as a measure of whether a woman is at risk for breast
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cancer but that ultrasound techniques were being studied to use with conventional
mammogram.
The U.S. Food and Drug Administration approved the first ultrasound machine to
image DBT in September 2012 (FDA, 2012). Because 226,870 women would be
diagnosed with breast cancer in 2012, and 38,510 would die from the disease, the agency
recognized the need for another imaging option for DBT (FDA, 2012). The FDA
approved the first Automated Breast Ultrasound System (ABUS) to image DBT using a
technique that was faster, more efficient, and surpassed the images produced by other
ultrasound machines. This technique was approved for use in patients with DBT who had
had negative conventional mammograms. However, the ABUS system has a specific
exclusion criterion for its application: It does not include women who had prior clinical
breast interventions such as surgeries, were pregnant, or were breast feeding, because
these factors can alter the appearance of breast tissue (FDA, 2012). In addition, the use of
the ABUS system must follow the ACS’s BI-RADS categories for density and
composition as shown below:
1. BI-RADS 1: The breast is almost entirely fat (<25% glandular).
2. BI-RADS 2: There are scattered fibro glandular densities (approximately 2550% glandular).
3. BI-RADS 3: The breast tissue is heterogeneously dense, which could obscure
detection of small masses (approximately 51-75% glandular).
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4. BI-RADS 4: The breast tissue is extremely dense. This may lower the
sensitivity of mammography (>75% glandular. (ACR, 2012, p. 5; FDA, 2012)
In an analysis of 100,000 women with DBT, there were many false positive
results, and some patients were referred for additional imaging or for unnecessary
workups (FDA, 2012; Kloten et al., 2013). MRI has a high sensitivity for breast cancer
detection, but it is currently used for high risk patients and not for DBT screening (Berg,
2011; van Goethem et al., 2009).
MRI Use for Dense Breast Tissue
MRI uses a “strong magnetic field, hydrogen protons in the water of the body,
radio waves, surface coil, and a specialized computer to image soft tissues and organs
inside the human body” (Frank, 2011, p. 330). The physics of this technique allows to
clearly see inside dense breast tissue where anomalies can remain hidden and metastasize
if they are cancerous and remain undetected (RSNA, 2013). This technique can also
produce 3-dimensional, high resolution images which can be reformatted to any
orthogonal plane where the breast anatomy and anomaly can be best visualized (RSNA,
2013). Additionally, this technique does not use ionizing radiation, which can place the
patient at risk of dangerous radiation exposure if additional imaging is needed (WebMD,
2013). MRI imaging is noninvasive, but an MRI examination of the breast may be less
tolerable to the patient, as it may take up to 30 minutes. Additionally, certain metal in the
body automatically excludes MRI examination due to heating, torque, and potential
malfunctioning of the implanted metal (Shellock, 2012).
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MRI was introduced for clinical use in late 1970, but it was not until 1991 that it
was approved by the FDA for breast imaging (Imaginis, 2013). In the 1980s, researchers
further studied breast imaging and discovered MRI techniques could differentiate
between normal and abnormal breast tissue (Hendrick, 2008). This MRI technique was a
breakthrough for imaging breast cancer, and the added incentive was that the technique
was noninvasive. MRI of the breast can be used to detect anomalies in unilateral or
bilateral breasts, the chest wall, axillary regions and surrounding areas of the chest (ACR,
2013). In addition, MRI can evaluate questionable anomalies identified on mammograms
and ultrasound exams (Radiologyinfo, 2013). The approval of MRI was embraced by the
breast cancer community due to its sensitivity to breast anomalies detected in a
mammographic examination. Although the use of breast imaging techniques such as
mammograms and ultrasound are still recommended, renowned cancer registries such as
the ACS (2012) and ACR (2013) stated that MRI excels at imaging dense breast tissue
because this technique has a very high sensitivity to dense breast tissue.
MRI is also useful to image younger women that are not predisposed to breast
cancer, but have dense breast tissue (Berg, 2009). This group is asymptomatic and not
predisposed to breast cancer, that is, no family history of breast cancer, and therefore
cancer can be undiagnosed. This group falls under the 40 year old group, which is the age
that agencies and organizations such the ACS, ACR and CDC recommended that women
should be screened for breast cancer (ACR, 2013; ACS, 2012; CDC 2012). Also women
that are in the menopausal status and take hormone therapy medication are at risk for
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dense breast tissue (ACS, 2013). Cancers in DBT for this group that can be missed by
mammogram screening for breast cancer, but MRI provides very clear images of
anomalies that can see inside dense breast tissues (Hendrick, 2008). In addition to breast
imaging, MRI is widely used to image women with augmented breasts, surgery planning,
both implants and post-surgery (Berg, 2009). However, MRI examinations also led to
false positive findings (Elmore et al., 2013; Imaginis, 2013), and as a result, ACS does
not recommend an MRI for breast screening, as it may lead to unnecessary invasive
breast procedures. But when MRI is compared to conventional mammogram and
ultrasonography for breast cancer screening, false positive findings are fewer. Therefore,
the literature showed that there is a significant benefit to use MRI for breast imaging.
However, breast cancer agencies and organizations do not provide guidelines that MRI
can be used to screen asymptomatic women with DBT.
Scholarly Literature
In a 2012 report, the ACR recommended and applauded the use of conventional
mammography for breast cancer screening and suggested that women who are
predisposed to breast cancer because they carried the BRCA gene or whose close
relatives have a breast cancer history should seek supplemental breast imaging (ACR,
2012; ITN, 2013). However, the ACR did not provide recommendations for screening of
DBT and offered the same recommendation in 2013. The ACR (2012) stated that
although MRI can detect cancers in dense tissue that cannot be seen on a mammogram,
some of these findings are not cancers which can result in unnecessary biopsies. Yet, the
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ACR (2012) suggested that if breast cancer is detected early, treatment can be done at the
early stages after cancer detection, but the ACR does not provide recommendation for
asymptomatic women with DBT.
Likewise, the CDC has not provided a recommendation that a diagnostic imaging
technique should be used to screen women with DBT (CDC, 2011). What the CDC
recommended is that DBT can be screened using scintimammography (2011), an imaging
technique where a radioactive tracer is injected intravenously and images of the breast
taken to show if the tracer attaches itself to the cancer cells in the breast tissue (ACS,
2013). This technique is used to image DBT for high risk patients, but it is not
recommended for screening the dense breast population (CDC, 2011). Like the ACR and
ACS, the CDC does not recommend a screening method for DBT. Although the ACR,
the ACS, and the CDC are advocates for early breast cancer screening that can lead to
early treatment of the disease, they do not recommend imaging protocols for DBT.
The ACS recommended that women 40 years and older should have a screening
mammogram every year, and women between 20 – 30 years of age should a clinical
breast exam every three years (ACS, 2014). In addition, the ACS recommended against
using MRI as a screening tool to screen women for breast cancer whose lifetime risk of
breast cancer is less than 15% (ACS, 2014).
Similarly, the NCI reported that other imaging technologies are being developed
to detect tumors, but did not have recommendations for imaging DBT for screening
(NCI, 2012). The NCI stated that a patient with a high mammographic breast density,
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which is a marker to develop breast cancer, does not indicate increase mortality rates for
breast cancer. The NCI stated that more research is needed to recommend MRI as a
screening tool for asymptomatic women with DBT (NCI, 2012).
The FDA has recommended diagnostic imaging options including
ultrasonography, scintimammography, thermography, and digital breast tomosynthesis,
but the FDA has not recommended a screening tool for DBT (NCI, 2011, p. 22).
Although the FDA a regulatory amendment that women in all states should be informed
if there is a DBT finding, they do not provide a recommendation for additional screening
for asymptomatic women with DBT (FDA, 2013).
Some state government officials have declared that physicians must inform their
patients if they find DBT during a screening mammogram. Senator Joe Simitian of
California, Senator Jeremy Ring of Florida, Governor Rick Perry of Texas, and
government officials from Alabama, California, Connecticut, Hawaii, Indiana, Maryland,
New York, North Carolina, Nevada, Oregon, Tennessee, Texas and Virginia have
advocated that physicians must inform their patients if there is a dense breast finding
(ACR, 2013; Simitian, 2012; Florida Senator, 2013; Henda’s Law, 2012; Diagnostic
Imaging, 2012). In states such as Utah, Maine, and Illinois, it is optional for physicians to
inform their patients if they find DBT during a screening mammogram (ACR, 2013).
Massachusetts, Michigan, New Jersey, Michigan, New Jersey, Ohio and Pennsylvania are
states that have pending legislation to inform patients if there was a DBT finding during a
screening mammogram (ACR, 2013).
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In a 2012 article, the NCI reported that 2,800 women with DBT were screened for
breast cancer. Data obtained from 612 women showed an increase in cancer detection
using ultrasonography, but this finding led to breast biopsies that yielded a small number
of positive breast cancer findings (NCI, 2012). The same group of 2800 women with
DBT was screened using MRI. Although MRI yielded a higher number of positive breast
cancer cases more than mammography and ultrasonography, the NCI stated that breast
density does not influence breast cancer mortality (NCI, 2013).
The Cochrane Collaboration provides health information to evaluate the
possibility of a risk or advantages of a specific condition. The Cochrane Database of
Systemic Reviews reported that screening mammograms can lead to 30% over diagnosis
and overtreatment, and it remains unclear if screening mammograms benefit or harm
women (Cochrane Summaries, 2011). The Cochrane Collaboration has also not issued
recommendations for DBT screening. The United States Preventive Services Task Force
(USPSTF), an independent organization that studies and recommends screening practices
to health systems, suggested that women should be screened for breast cancer biannually
from ages 50 to 74 years of age but not routinely screened from 40 to 49 because there is
not enough research data to warrant the need for screening (2009). Further, the USPSTF
suggested that it should be the choice of women to decide when routine screening for
breast cancer should begin, but the organization has not made recommendations for DBT
screening.
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The following states have laws that require physicians to inform patients of DBT
findings: Alabama, California, Connecticut, Hawaii, Indiana, Maryland, New York,
North Carolina, Nevada, Oregon, Tennessee, Texas and Virginia. However, they but do
not mandate a referral for this population for additional imaging, such as an MRI or
ultrasound, only that other imaging options be available (ACR, 2013; Brower, 2013).
Other imaging options are available for women at high risk for breast cancer, but not for
asymptomatic, women with DBT (Wood et al., 2013).
Gap in the Literature
Further breast cancer screening for DBT stops after there is a DBT finding,
according to the Susan G. Komen Foundation (2013). A strong advocate for breast cancer
prevention and treatment, Komen states that there is not an imaging method to screen the
dense breast population and that physicians do not normally use breast density numbers
to make a breast cancer diagnosis. However, since 2009, the Breast Density Inform law
in the United States has required that physicians inform women of their breast density
numbers. Subsequently, 11 states require physicians to inform women of their breast
densities (Pushkin, 2013). Although this is a positive step for women with DBT, there is
not a follow-up after the finding. The ACR, ACS, and the NCI have also reported the
need for an adjunct imaging method to complement conventional mammography for
DBT, but MRI is used only for women in the high-risk population, those with a history of
breast cancer, a strong family history of breast cancer, atypical hyperplasia, and DBT
(Saslow et al., 2009).
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MRI and Sonogram for Dense Breast Tissue Imaging
Ultrasound methods can detect 30% more cancer than mammograms
(AuntMinnie, 2010) and is useful for identifying breast anomalies such as protuberance,
swelling, nipple discharge, fluid-filled cysts, and for differentiating between solid and
fluid-filled masses (RSNA, 2013). Ultrasound imaging for DBT can be used with
conventional mammograms as an adjunct for breast screening, but both ultrasound
imaging and conventional imaging can miss 22% of cancers in DBT, but MRI has shown
a high sensitivity to image DBT (Radiologyinformation.org, 2013). Currently, MRI is not
used for breast cancer screening except for high-risk cases, although it has yielded more
breast cancer findings.
Literature Related to Research Methods
A mixed methods design was used for this investigation of whether there is a need
for an additional method to image women with DBT. The quantitative approach was also
used to test the hypothesis, using statistics from the CDC, ACR, and ACS. Secondary
data was collected from those cancer registries to determine whether a method is needed
as an adjunct to conventional mammography. This quantitative data was analyzed to
inform the qualitative phase of the study (Creswell, 2009).
The second phase was a qualitative approach that builds upon the first.
Descriptive statistics were collected from answers women give about the methods used to
image their DBT (Simon & Goes, 2013). Answers provided richer data about the
accuracy of the method used for screening mammograms.
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Summary
In this chapter, I presented a review of literature published within the past 5 years
that asserts that conventional mammography can miss cancer in DBT because this
imaging method has a low sensitivity to DBT. Ultrasonography to image DBT was also
reviewed as was the sensitivity of MRI for breast cancer screening. The purpose of the
literature review was to highlight the sensitivity of ultrasonography and MRI techniques
as screening methods for DBT.
Chapter 3 describes the method I followed to collect secondary data from cancer
registries such as the CDC, ACS, ACR, and NCI to support whether an adjunct imaging
tool is needed in conjunction with conventional mammography to image DBT. In
addition, it describes how I collected qualitative data from a small group of women in
San Jose, California, who responded to survey about their experiences with breast
screening options used for their mammograms.
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Chapter 3: Research Method
Introduction
The purpose of this study was to determine to what extent conventional
mammograms can miss breast cancer in women with DBT and to determine if an adjunct
method of imaging DBT might detect breast cancers missed by mammography alone.
Although the ACS, ACR, and CDC advocate early detection and treatment of
breast cancer, they do not mandate imaging options for breast cancer screening for
women with DBT by. (ACR, 2013; ACS, 2012; CDC, 2013). Because conventional
mammograms detect less than half of cancers in DBT, many breast cancers are missed
(Are You Dense? 2013). As a result, there was a need to determine if there is an
additional method for screening women in the DBT population.
Most of the literature in Chapter 2 concluded that mammography should still be
used, but that an adjunct method with a high sensitivity to detect cancer in glandular
tissue is needed (Berg, 2009; Susan G. Komen, 2012; Zonderland et al., 2013). For those
reasons, I explored whether there was a need for ultrasonography and MRI—two
standard alternatives--following a determination of DBT (Creswell, 2012). A mixedmethods design was determined to be best suited for this study because they provide
complementary approaches to learning more about a topic that has both physical and
emotional aspects. Greene, Caracelli, and Graham (1989) asserted that research is
enriched using mixed methods (as cited in Simon & Goes, 2013).
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Before I collected any data, I submitted a proposal to the Walden University
Institutional Review Board for approval and was given Approval No. 10-07-14-0078441.
The first results are from the quantitative strand, which tested whether an adjunct method
of screening is needed for the 40% of women with DBT. In the second strand, responses
from women with DBT (which included the imaging methods used for their breast cancer
diagnosis), illustrated the qualitative or personal effects of their experiences. Creswell
(2009) emphasized that using both quantitative and qualitative strands of inquiry can
provide broader insight into a question. Campbell and Fiske (1959), Jick (1959), and
Plano Clark (2007) also supported the use of the mixed methods design and noted that
this approach allows for integration of data, which can produce stronger results.
Quantitative data are important in a mixed-methods explanatory design because
the data can explain a phenomenon using objective data and analysis. Quantitative
analysis began with a random, yet systematic sampling of secondary data about breast
cancer from the following cancer registry databases: ACR, ACS, CDC, the California
Department of Public Health (CDPH), and the NCI. From that information, I selected
every 20th person until I had 500 names using G*Power, a power analysis tool used to
calculate the appropriate number of participants (Faul, Erdfelder, Lang, & Buchner,
2007). The process also followed recommendations by Creswell and Plano (2011) and
Rudestam and Newton (2007).
An introductory e-mail was sent to the selected sample to explain the rationale for
the study and request their responses. I secured permission from each person, obtained an
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electronically signed consent from those willing to participate, explained online access,
and told them the closing date for participation (Creswell & Plano, 2011; Rudestam &
Newton, 2007). Systematic random sampling can eliminate bias by ensuring everyone in
the sample population has an equal opportunity to participate and to ensure the results of
the survey are representative of the population (Creswell & Plano, 2011; Teddlie &
Tashakkori, 2009). Data collected were synthesized, analyzed, and tested by inferential
data analysis using ANOVA (Hoare & Hoe, 2013; Norkett, 2013). Results from the
quantitative strand led to the qualitative strand.
The qualitative strand was guided by the phenomenological inquiry approach of
Moustakas (1994), who stated that the goal of phenomenological inquiry is to bring to
light the lived experiences of persons who have experienced a phenomenon. This
investigation highlights the lived experiences of women with DBT and the time it took to
determine if cancer was present when conventional mammography and MRI were used.
Based on phenomenological philosophers such as Husserl, Kierkegaard, Heidegger, and
Sartre, I chose a phenomenological approach because the inductive method can gather
data through interviews to explain lived experiences of participants (Simon & Goes,
2013). These data bring a deeper explanation of a phenomenon because it comes from
women who have experienced it (Moustakas, 1994).
Although the qualitative method could have been the sole research method, I also
used quantitative data to add objectivity (Creswell & Plano, 2011; Teddlie & Tashakkori,
2009). Additionally, intertwining the strands can create a more robust study because
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together they contribute different avenues of information to the investigation (Rudestam
& Newton, 2007). The qualitative strand can provide richer data to build upon the
quantitative strand to help the researcher understand and put findings from the
quantitative strand into perspective (Creswell & Plano, 2011; Rudestam & Newton, 2007;
Teddlie & Tashakkori, 2009). Qualitative data include the subjective responses of
participants that provided their lived experiences (Houghton, Casey, Shaw, & Murphy,
2013). Frels and Onwuegbuzie (2013) suggested that the researcher has more flexibility
in the qualitative approach because of the natural environment where data are collected,
the explicit process, and the open-ended nature of questions for data collection. In
addition, responses to open-ended questions can yield detailed responses that may lead to
a deeper understanding of the premise of the research (Frels & Onwuegbuzie, 2013).
Chapter 3 describes the research design as suggested by Creswell (2009), Plano
Clark (2007), and Campbell and Fiske (1959) and includes the research design, the role
of the researcher, the methodology, description of the research instruments to include
validity and reliability, the data analysis plan, and ethical procedures.
Research Setting
The time and place (some natural setting) for the qualitative strand were
controlled by the participants. I was sensitive to the wishes of the participants and wanted
them to feel at ease (Simon & Goes, 2012). The aim of the survey was to learn the feeling
of the population through open-ended questions that gave them time to reflect, think
about the questions, and provide answers that were as brief or detailed as they chose.
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Data were collected through telephone interviews, and conversations were recorded with
participants’ permission. The recordings provided repeated listening time for
organization, identification of themes, coding, and analysis (Creswell, 2007).
Research Design and Rationale
Research Questions
Research Question 1 (quantitative): Should MRI be used for screening women
with DBT as an adjunct to conventional mammography?
H0: MRI technique for screening women with DBT should be used as an adjunct
to conventional mammography.
H1: MRI technique for screening women with DBT should not be used as an
adjunct to conventional mammography.
Research Question 2 (qualitative): What were the lived experiences of women
with breast cancer in DBT prior to and after the breast cancer diagnosis?
Sub Question 1: What were the circumstances that prompted the need to screen
for breast cancer?
Sub Question 2: How were the lives of women with a DBT cancer diagnosis
impacted from the initial breast cancer screening to the final breast cancer diagnosis?
Sub Question 3: How does DBT with a cancer diagnosis affect the lives of women
with the disease?
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Sub Question 4: How can the addition of an adjunct imaging method such as MRI
to the existing method help to bring a deeper understanding of the need for efficient
screening methods and a definite diagnosis of cancer in DBT?
The independent variable was using MRI imaging techniques to screen women
with DBT. The dependent variable was breast cancer detection for women with DBT.
Mixed Methods
The research design was a mixed methods explanatory approach (Creswell &
Plano Clark, 2008). The quantitative strand was conducted first, and the qualitative strand
was used to build upon the results of the quantitative strand. Mixed methods research is
employed when the results of either a single quantitative and qualitative study does not
provide a complete understanding of the research problem (NIH, 2013). I employed the
quantitative approach to test the hypothesis with statistical analysis and the qualitative
method to reveal data that reflect real life experiences of participants (NIH, 2013).
Boeije, Slagt, and van Wesel (2013) employed mixed methods to study childhood trauma
and found that the integration of the quantitative and qualitative strands provided
additional knowledge about their research topic. Boeije et al. (2013) also found that using
mixed methods allowed them to draw conclusions and make recommendations for
improvement of the quality of life for their subjects. Heyvaert, Hannes, Maes, and
Onghena, (2013) also supported the use of the mixed methods design and reported that it
is useful in health and health-related subjects and can answer research questions in these
fields. Pluye, Gagnon, Griffiths, and Johnson-Lafleur (2009), reported that a stringent
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review that analyzed the mixed methods approach revealed “convenience, reproducible,
and systematic” qualities (p. 532).
For the quantitative phase, I collected data using systematic random sampling to
fulfill the equal likelihood chance of selection and randomness for the target population
(Banerjee & Allen, 2010). The random sample was selected from a potential population
of 10,000 women, ages 24–74, who had a consecutive mammogram within the past 2
years, and selection was every 20th person in that population until the number selected for
the sample was reached (Simon & Goes, 2012). The geometry of data collection can
generate sufficient power so that results can be applied to the general population. Gay
and Suskie (as cited in Simon & Goes, 2012) suggested that if a 250 effect-size sample is
used for a study, results should be applicable to the general population of similar subjects.
The qualitative phase was purposeful sampling (Moustakas, 1994) because this
strategy can yield a typical population (Creswell, 2007, p. 125; Moustakas, 1994). The
phenomenological approach illuminates the research statement because experiences from
participants can provide a better understanding of a topic through rich data collected
during interviews. Twenty participants were selected for this portion of the study.
According to Creswell (2007), a smaller sample allows a researcher to spend more time
with each participant and potentially glean richer information. Participant data were
collected from a full service breast imaging center in a specific demographic region of
San Jose, California. Because of the California law requiring that women with a dense
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breast finding on a mammogram must be reported to the California Department of Public
Health (CDPH), data for this group were available and accessible.
I sent a letter of introduction with information about the study and its purpose and
goal to potential participants. The letter included my contact information, asked if they
wanted to participate, and asked them to call me if they wanted to be part of the study.
One week after they responded in the affirmative, I called to confirm their acceptance and
answer any questions they had. The process continued with informed consent material
and ethical information. Upon receipt of the signed informed consent, I called again to
determine the best time for a telephone interview. To eliminate bias, I called those who
did not respond to confirm that they were not interested in participating, and added their
responses to the total number of participants. With the permission of the interviewee, I
recorded their answers, transcribed and coded them to protect identities, and stored the
information for analysis using NVivo. Constructs that were used to measure qualitative
data encompass “credibility, transferability, dependability, and conformability”
(Rudestam & Newton, 2007, p. 112). This process should ensure the study can be
considered believable and fulfills the requirements that data can be transferred for
quality, trustworthiness, replication, and objectivity for a replicated study (Lincoln &
Guba, 1985; Rudestam & Newton, 2007).
Results from both strands were combined to connect both datasets; the qualitative
approach builds upon the quantitative phase and was used to support the results of the
quantitative strand. Both phases were embedded to form a comprehensive representation
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of the research problem (Boeije et al., 2013; Creswell, 2006; Franz et al., 2013; Heyvaert
et al., 2013). The goal is to produce robust results that might not be attained using only
one method.
Role of the Researcher
Creswell (1998) said a researcher must be aware of the basic fundamentals of the
selected method of inquiry and must have a clear understanding of the research processes.
For this study, I used quantitative data from cancer databases of the ACR, ACS, CDC,
and the NCI for a specific area of California between 2010 and 2012. For the qualitative
inquiry, I designed the questionnaire, pilot tested it, administered it, and then collected
and analyzed resulting data (Creswell, 1998; Simon & Goes, 2013). For a robust
experiment and outcome, the researcher must disclose biases, suppositions, and
perspectives (Creswell, 1998; Simon & Goes, 2013). To assure my objectivity, I put aside
personal biases during the interviews, did not lead participants to respond in a particular
way, and kept a journal for personal reflections (Simon & Goes, 2013).
Methodology
Selection of Participants for Quantitative Data
Records of 10,000 women ages 24 to 74 were taken from the 2010-2012
databases of the ACR, ACS, CDC, CDPH, and NCI to identify those who had a diagnosis
of DBT. From that group, every 20th name was selected to participate, yielding a potential
N of 500 (Trochim, 2001). The confidence level was expected to be 95% with a margin
of error of 5% (Simon & Goes, 2013). A t test was used to measure two independent
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samples of conventional mammography and MRI imaging methods (Simon & Goes,
2013). A broad age selection follows what breast cancer foundations and registries report
and should reflect accurate application to both older and younger women. Younger
women inherently have DBT, and most postmenopausal women who are not using
hormone replacement therapy also have DBT (Berg, 2009). The systematic random
sample means each woman with a dense breast finding has the same chance of being
selected (Creswell, 2007). Power analysis was used to calculate an adequate sample size
for a statistical test (Rudestam & Newton, 2007). If a sample size is too small, the
investigation will not have enough power to answer the research question adequately. If a
sample is too large, it can create inaccuracies by highlighting insignificant variables,
making the goodness-of-fit test too sensitive and leading to the determination that 500
participants would be required (Rudestam & Newton, 2007; Simon & Goes, 2012). The
quantitative survey (See Appendix B) consisted of 11 questions with a Likert rating scale
of five choices. The survey is comprised of the following questions.
1. Is your age between 24 and 74 years?
2. Are you in good health?
3. Do you have a family history of breast cancer?
4. Have you lost a family member to breast cancer who had regular
mammography screenings?
5. Do you regularly perform a breast self-exam?
6. Do you have an annual screening mammogram?
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7. Have you had screening mammograms every year for the last 5 years?
8. Have you had an abnormal mammogram finding?
9. Did your doctor tell you that the result of your mammogram was not
conclusive?
10. Is this the only available way you know of to screen for breast cancer?
11. Do you know women who had normal mammograms during their years of
screening and have had a subsequent breast cancer diagnosis?
Qualitative Selection
Participant selection for interviews followed the guidelines for purposeful
sampling (Creswell, 2007). Because this investigation follows the guidelines of
phenomenology theory, a sample size of 20 participants was selected from the database
of the California Department of Public Health (CDPH), from 2010 to 2012 using a fullservice breast-imaging center in San Jose. California physicians are required to report
dense breast findings, and as such, information for this region is accessible for research.
General information for contacting participants is also available for research purposes. I
secured permission to have access to the study population.
Qualitative recruitment began with an introductory letter e-mailed to 20 potential
participants. The letter explained the study, who I am, and my contact information. Those
who agreed to participate were sent an informed consent form that included a stamped,
self-addressed envelope for returning the signed form. The informed consent explained
the purpose of the study, what the findings will be used for, how information will be
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collected, and the duration of the interviews. It also explain that there is no compensation
for participation, that participation is voluntary, and that no personal information will be
shared in any subsequent presentation of the results of the study. It also encouraged
participation by telling participants the results might help other women who have had
experiences similar to theirs. An informed consent document is shown at Appendix D.
The respondents and researcher arranged the time for the interviews via e-mail. The semistructured interview will follow a script (Appendix C) and consist of open-ended
questions as follows:
1. Are you in the age group 24 to 74 years?
2. Do you perform routine breast self-exams?
3. Do you have a family history of breast cancer?
4. Do you have an annual mammogram?
5. Do you have DBT based on a mammogram?
6. Were you told by her doctor that you needed a repeat mammogram?
7. Have you had an ultrasound as a breast cancer screening? What was the
finding?
8. Did an MRI confirm your breast cancer diagnosis after the abnormal
mammogram finding?
9. Describe your emotions before your doctor diagnosed your breast cancer.
10. Do you believe your breast cancer could have been detected earlier if MRI
was used after your initial cancer diagnosed accusing mammograms?
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To eliminate bias, I sent a follow up e-mail to nonrespondents and added the
numbers to the total number of participants.
Quantitative Instrumentation
Instrumentation followed the guidelines of the mixed methods explanatory
research design, where quantitative data collection is followed by qualitative data. For the
quantitative phase, the survey instrument collected data from women with DBT who had
a mammogram between 2010 and 2012 from databases of the ACR, ACS, CDC, CDPH,
and NCI. SurveyMonkey was used to send surveys and collect responses to record each
answer (Simon & Goes, 2012). SurveyMonkey is a fee-for-service program that enables a
researcher to design an instrument for a targeted group and direct responses to a secure
online site for retrieval. SurveyMonkey was appropriate for the quantitative strand of this
experiment because it generates closed-end questions and collects responses for large
populations in a short time (Simon & Goes, 2012). SurveyMonkey was downloaded to
SPSS for analysis. Quantitative design studies in the nursing discipline (Hardy, 2011),
social media (Roe, 2013), and social research (Stein, 2011) that used SurveyMonkey for
data collection and analysis demonstrated the validity and reliability of the instrument.
Validity and Reliability of the Quantitative Instrument
If an instrument executes what it is intended to evaluate, then it is considered
valid (Creswell, 2007). The face and content validity for the survey instrument were be
tested for strengths and weaknesses. Content validity was corroborated by the cover letter
and the survey content and was pilot tested before it was sent to participants. Glicken
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(2003) suggested that the sample size chosen for the experiment must represent the target
population. As noted before, G*Power, a computer software tool, was used to calculate
the sample size for the quantitative portion of the study.
Reliability of the survey instrument was measured for its reproducibility, stability,
and consistency (Creswell, 2007). Test and retest were also used to measure reliability.
with the determination that if same assessment were given to the same group, and the
same procedures were replicated, then the results should be consistent, making the tool
reliable (Creswell, 2007). SPSS was used to test the reliability of the Likert-type scale
questions using Cronbach’s alpha (Frankfort-Nachmias & Nachmias, 2007; Simon &
Goes, 2013).
Qualitative Instrument
Qualitative data came from open-ended interviews (Patton, 2002, p. 4). Patton
(2002) suggested that interviews provide responses that can lead to a better understanding
of a research question. The interviews were guided by a short-answer questionnaire I
conducted. The conversations with participants were recorded for later review. Creswell
(2007) suggested that open-ended questions allow a researcher to control the questioning
and prompt participants for more details (Creswell, 2007, p.179). I encouraged
participants to speak freely about their experiences with the disease during the 30-minute
interviews.
The questions I used were guided by a focus on the following:
1. What is the goal of the interview?
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2. What am I attempting to find out?
3. Why is the information needed?
4. Are the questions reasonable?
5. How will the results help to identify additional breast cancer screening
methods for women with DBT?
Validity and Reliability of the Qualitative Instrument
Credibility, conformability, consistency, and applicability are criteria used to test
a qualitative instrument (Lincoln & Guba, 1985; Rudestam & Newton, 2007). The
premise of qualitative research is to explain the phenomenon and to create a better
understanding of the topic. Lincoln and Guba (1985) argued that an instrument must be
believable. It must capture data in the correct setting, where correct procedures are
followed for data collection, and the researcher must have participant consent for that
data collection (1985). Credibility of the instrument can also lead to greater
generalizability of the results (Johnson, 1997; Stenbacka, 2001).
The third test an instrument must undergo is conformability: A plan must be
evident in the research report, and member checking of the answers must be done to
eliminate researcher bias (Lincoln & Guba, 1985). If the researcher is biased, the bias
may influence the data collection procedure and subsequent analysis, and the study may
not be fundamentally solid. The fourth criterion is consistency. Campbell (1996)
suggested that the consistency of the instrument can be validated by the assessment of
source data and progression notes. This process was done by checking for missing data
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sets, repeating questions for consistency, and clarifying answers with participants for
transparency.
Procedures for the Pilot Study
Before any contact was made with participants, I had permission from the IRB at
Walden University, IRB Approval # 10-07-14-0078441, to pilot test the questions before
they were asked of participants. The purpose of this was to find and correct errors in
content or wording, based on responses from the pilot study group (De Kok et al., 2010).
Results were discussed with an experienced principal investigator to ascertain if
responses given by the participants fit the criteria of credibility, conformability,
consistency, and applicability that Lincoln and Guba (1985) proposed.
The purpose of a pilot study is to test the achievability of the full scale study,
determine the possibility of its success, and highlight barriers that may affect the progress
and completion of the study (De Kok et al., 2010; Given, 2008). The pilot study
questionnaire consisted of the following questions:
1. What age group are you?
2. What prompted you to get breast imaging?
3. Were you told that you have DBT?
4. What was your breast density measurement?
5. What kind of breast imaging did you have? Ultrasound or MRI?
6. Which one was first?
7. What did the uultrasound find? What did the MRI find?
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8. How long did you wait before you were given a diagnosis?
9. Did you receive treatment?
10. What is your prognosis?
Based on responses to the pilot study, I determined the questions elicited the
information I was seeking (De Kok et al., 2010). I then evaluated the answers and
changed questions as necessary (Lincoln & Guba, 1985). To further authenticate the
study, I requested a panel of three experts in the field of breast imaging and breast cancer
research to provide expertise in their breast cancer imaging methods and imaging
methods for DBT.
Panel of Experts
The expert panel for the pilot study was comprised of one breast cancer clinical
physician, one radiologist who interprets breast cancer imaging examinations, and one
PhD breast cancer researcher, as they know disease diagnosis, interpretation of imaging
for breast cancer, and the research about the disease. I sent an introductory e-mail to each
to achieve
1. An introduction to the researcher
2. The purpose of the pilot study.
3. An explanation of how their participation will help the study.
4. Determination of their interest in participating
Based on their responses, I called to confirm their interest and told them the
deadline for completion and feedback for the questionnaire, that I would communicate
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with them by e-mail, and that I would amend the qquestionnaire as needed based on their
responses. The questionnaire for the expert panel is included at Appendix F.
Data Analysis Plan
Quantitative
The null and alternative hypotheses below were considered in the data analysis
plan.
H0: MRI technique for screening women with DBT should be used as an adjunct
to conventional mammography.
H1: MRI technique for screening women with DBT should not be used as an
adjunct to conventional mammography.
Statistical Package for the Social Sciences (SPSS) was used for the data analysis
for the quantitative strand. Data collected from the surveys reflected both respondents
and nonrespondents will be added to the computation to eliminate bias, as referenced by
Creswell (2009). Creswell suggested that the inclusion of nonrespondents could
potentially address and eliminate bias in the study and could show whether the research
findings might change the study.
The initial step in the data analysis process followed processes described by
Trochim (2001), Creswell (2009), and Simon and Goes (2013). Data analysis followed
the steps of data entry, data organization, data screening, and data cleaning. After I
collected data, I organized and prepared it in a logical form using an Excel spreadsheet
then screened and cleaned it by a visual check and comparison with the raw data I had
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collected (Trochim, 2001). I further evaluated the information by a visual check of the
printed data and used a text editor to check for inaccuracies and errors (Jarausch &
Hardy, 1991, p. 53). Additionally, I cleaned data by checking for duplicate records,
missing data sets, and inconsistencies. Any errors were corrected and reentered into SSPS
(Jarausch & Hardy, 1991).
Data screening was used to check for data accuracy by use of histograms and
charts. I also performed a visual check for admissible and impossible values in the
datasets, a process that helped to locate and edit incorrect data (Jarausch & Hardy, 1991,
pp. 40-41; Simon & Goes, 2012, p. 185). Interval data was the level of measurement
because these kinds of data have an order that follows the Likert scale (Creswell, 2009;
Simon & Goes, 2013). The sequence of quantitative data analysis for the study followed
with the selection of the statistical test.
The two-tailed t test was then used to test the hypothesis that MRI or ultrasound
should be used to screen for breast cancer in the dense breast population (Field, 2009). A
two-tailed test was used because the hypothesis is nondirectional, meaning that the claim
neither supports nor rejects the hypothesis (Field, 2009). Hypothesis testing was done
with the use of the probability or p value method, a statistical test to show the power of
what is being tested (Simon & Goes, 2013). If the p value has a value that is less than
0.01, there is a possibility that the null hypothesis will be rejected (Simon & Goes, 2013).
Hypothesis testing for this study was done to accept or reject the null hypothesis (Field,
2009). I then organized the data for presentation in table format.
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Qualitative
The initial step in data analysis is data review. For this process, I applied data
reduction, where large amounts of data collected from the interviews were organized and
prepared for analysis (Creswell, 2009). I then reviewed and examined the information to
understand meanings and reveal concepts about what participants said about their
experiences. I also followed the inductive process of axial coding. Creswell (2009),
Trochin (2001), and Rudestam and Newton (2007) recommend axial coding as part of
data analysis because the process can find commonalities. In addition, I used preset codes
to find common words and phrases and looked for emergent codes that arose from the
data. Axial coding, preset codes, and emergent codes identified specific words and
phrases from the interviews. Although Creswell (2009) recommends that the emergent
code method is commonly used for social science studies, preset codes for this mixed
methods investigation illuminated the importance of the topic. At this juncture, Creswell
(2009) also recommended that the researcher should review the coded data again for a
holistic view of the research phenomenon, recheck the raw data collected from the
interviews, and recheck codes assigned to data already reviewed, an additional step that
aids a qualitative researcher to check for missed codes and perhaps add new codes to the
data. The data were then checked for similarities, differences, patterns, and relationships
by an Excel matrix to provide a holistic view of the phenomena (Miles & Huberman,
1994). Coded data were downloaded to NVivo for final analysis (Creswell, 2009). At this
point, I review the findings, interpreted how the findings of the investigation supported or
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did not help to support the research question, and drew implications from the findings to
be represented in a narrative format (Krathwohl, 1988; Miles & Huberman, 1994).
Creswell (2009) recommended that a researcher can present the findings of a qualitative
study in narrative format and add tables, figures, and visuals as adjuncts to illustrate the
findings.
Mixing the Qualitative and Qualitative Approaches
Integration of the quantitative and qualitative strands in social research is
daunting, according to Creswell (2009). Among several mixed methods supporters,
Creswell (2009), Creswell and Plano Clark (2007), and Mackay (2004) suggested that
matrices such as timing, weighing, mixing, and theorizing (Creswell, 2009, p. 207) are
essential criteria researchers can follow in a mixed methods approach. The sequential
explanatory approach was used for this study because the quantitative approach alone
was not adequate to answer the research question. Therefore, I also employed the
qualitative to illuminate the findings of the quantitative findings. In addition, I used
triangulation to strengthen the sequential explanatory approach of the investigation.
Threats to Validity
Validity is a measure that accurately represents the true premise and the
soundness of the study (Hammersley, 1988). For a study to be valid, the researcher
follows the appropriate steps to achieve validity. However, there are threats that can
affect that validity (Creswell, 2009). The researcher must identify these threats and offer
potential solutions to enhance the credibility and feasibility of the study. External validity
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is a determination of how the precision of information and conclusions drawn from a
study can be generalized to the population. If the study does not meet these criteria, then
the study may be invalid (Seliger & Shohamy, 1989). Internal validity measures the
accuracy of the data collected and conclusions gathered that represent the phenomena
being studied. Internal validity also tests parameters within the design of the study itself
for inconsistencies (Seliger & Shohamy, 1989).
External Validity
Trochim (2001) suggested that external validity is a measure of how accurate the
data and the conclusion of the study are and whether they are generalizable to the
population being studied. One threat to external validity can be small sample size (p. 42).
For the quantitative strand of this study, I used random sampling so that each potential
participant had the same chance of being selected (Creswell, 2009; Trochim 2001). A
second threat to external validity could be lack of replicability or transferability. The
researcher must be aware of the clarity and simplification of steps and must note them
clearly for replicability (Creswell, 2009). The data collection instrument must do as it
purports to do, or there may be an external threat to the validity of the study (Creswell,
2009). External validity in qualitative research is the transferability of the findings to
analogous groups (Lincoln & Guba, 1986).
Construct Validity
A major threat to external validity could be construct validity, an assessment of
how efficiently the tools used in the research measure what the researcher wants to
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measure (Trochim, 2001). For this study, I used SurveyMonkey to collect quantitative
data, semi-structured open-ended questions to collect qualitative data, and a panel of
experts on the phenomenon being studied to triangulate the data. Wainer and Braun
(1988) stated that there must be a detailed step-by-step process for a study. If the
procedures are disorganized, a study can lose its credibility. Although Creswell and
Miller (2000) suggested that external validity does not affect qualitative research, the
researcher must be mindful of the sample size for the qualitative strand of the study. Data
must be collected until there is a saturation point and a model arises. This maneuver will
add to the credibility of the study and can show whether the researcher was scrupulous in
data collection and analysis.
Internal Validity
Threats to internal validity include lack of credibility, transferability,
dependability, or conformability. (Denzin & Lincoln, 1998; Guba & Lincoln, 1989;
Hammersley, 1987; Mishler, 1990; Wolcott, 1990). I conducted external audit checks and
triangulation to minimize threats to the study (Simon & Goes, 2013, p. 81). I also tested
questionnaires for reliability by member checking (Simon & Goes, 2013, p. 81). I also
used semi-structured, open-ended questions to collected data from participants; this tool
was reviewed by experts for construct and face validity (Creswell, 2009) and whether
they supported the phenomena I wanted to investigate.
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Trustworthiness
I added to the credibility of the study by collecting rich data from participants
who have lived with DBT, have been screened by traditional mammography, and may or
may not have been screened by an alternate method. Trustworthiness was measured by
transferability, in that the procedure could be shifted to another circumstance. I kept
detailed records during the study and followed stringent guidelines for data collection and
analysis processes.
Accuracy of transcriptions was determined by member checking to assure that I
recorded my questions and participants’ responses accurately. I sent transcripts of the
interviews for participant review and corrected or changed their responses at their
request. NVivo codes generated from themes in the data were recorded and applied
consistently.
Ethical Procedures
Researchers must follow ethical guidelines for the entirety of the research process.
I followed the guidelines of the Walden University IRB and collected data after I
received approval to conduct the study. There was no physical harm or risk to
participants in this study, and each gave signed consent and acknowledged that their
participation was entirely voluntary. Participants were told they could withdraw from the
study at any time. I identified participants by number only, and no personal information is
linked to the study. All personal data was considered confidential and secured in a
locked, fire-proof filing cabinet (Sieber, 1998). Data analysis results will be kept on a

60

password-protected computer that only I have access to. After 5 years, all data will be
destroyed.
Summary
This chapter presented the methods used to determine from women with DBT
what their experience has been with traditional mammography. The purpose of the study
was to determine whether the health of women with DBT who are not part of the highrisk population is endangered because there is no alternative screening method used as an
adjunct to traditional mammography.
Chapter 4 is a presentation of the results of the study and further observations.
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Chapter 4: Results
Introduction
The purpose of this mixed methods study was to investigate to what extent
mammograms can miss cancer in women with DBT and to find out if an adjunct method
of imaging DBT might detect breast cancers that are missed by mammography alone.
This chapter was organized to incorporate the research questions to determine which
diagnostic technique other than conventional mammography was most effective to detect
cancer in DBT. The two research questions were as follows:
Research Question 1: Should MRI be used for screening women with DBT as an
adjunct to conventional mammography?
Research Question 2: What are the lived experiences of women with breast cancer
in DBT prior to and after the breast cancer diagnosis?
A randomized survey research design was used to administer and collect
quantitative data. A two-tailed t test was used to test H0 using an Excel spreadsheet to
organize, manage, and track data. The Statistical Package for the Social Sciences (SPSS),
version 21, was used to analyze data collected. The second phase of the study utilized the
phenomenological approach. The purpose of this qualitative strand was to learn, collect,
and analyze lived experiences from participants between the ages of 24 and 74 years
about dense breast imaging and explore which diagnostic imaging techniques were used
to screen for breast cancer.
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This chapter includes the setting of the study, a brief discussion of the expert
panel, why the expert panel was used, participant demographics, data collection, and data
analysis. As noted in Chapter 3, the mixed methods explanatory design was employed
where data collection and analysis for the quantitative strand of the study was conducted
in the first phase (Campbell & Fiske, 1959; Jick, 1959; Creswell, 2009, & Plano Clark,
2007). The results of the study conclude the chapter.
Expert Panel
Experts on breast cancer research and diagnosis were used in this study to check
content validity of the research questions that I used for this study, to determine the
possibility of its success and to highlight any barriers that might affect its success (De
Kok et al., 2010; Given, 2008). All experts responded that the content of proposed
questions was appropriate, that the content of questions was simple enough for
participants and did not pose ambiguity. Based on this response from the expert panel,
there was no change in the wording of the proposed questions for the quantitative survey
and qualitative interview questions.
Setting
Surveys–Quantitative
I e-mailed surveys to a random sample of potential participants who had one week
to complete and return them. The survey contained 11 closed ended questions (Appendix
F). After 300 completed responses were received, I stopped recruitment.
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Telephone Interviews–Qualitative
A recruitment poster (shown in Appendix C) was placed at a breast care center for
1 week, with information about the study and my contact information to respond to if
there was interest in participating. At day four, I had received 10 responses. I contacted
each of them to explain the study, sent them follow-up e-mails, received consent to
participate in the study, and definite times were arranged to conduct the telephone
interview.
There were no personal or organizational conditions I know of that might have
influenced participants at the time of the study that may have affected my interpretation
of the study results. Neither those in the quantitative and qualitative parts of the study
were influenced or coerced to participate in the study as stated in the Consent Forms A
and B that were provided for them (shown in Appendix D and E). Each participant
understood that they had the option to withdraw from study participation at any time.
Participant Demographics
A sample size of 300 women participated in the quantitative part of the study and
10 respondents participated in the qualitative strand. A power analysis tool, G*Power was
used to calculate the appropriate sample of 300 participants for the quantitative part of the
study (Faul, Erdfelder, Lang, & Buchner, 2007). A sample size of 10 is judged sufficient
for phenomenological investigations (Rudestam & Newton, 2007).
Participants for the quantitative portion were randomly selected from women who
were residents of Santa Clara County in California, had a screening mammogram
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between 2010 -2012, were between 24 and 74 years of age, had no history of breast
cancer, and had a dense breast tissue finding. These criteria are outlined in Consent Form
A.
Participants for the qualitative part of the study were purposely selected from the
breast care center of Regional Medical Center of San Jose. They were residents of Santa
Clara County in California, had a screening mammogram between 2010 and 2012, were
between 24 and 74 years of age, had no history of breast cancer, and had a dense breast
tissue finding. These criteria are outlined in Consent Form B.
Data Collection
Quantitative
Three hundred participants for the quantitative were randomly selected from
Santa Clara County in California, and data were collected via SurveyMonkey, an online
data-collection service. All participants who agreed to participate in the study had the
option to stop the process after reviewing the consent form shown in Appendix D. The
survey contained 11 closed-end questions:
1. Is your age between 24 and 74 years?
2. Are you in good health?
3. Do you have a family history of breast cancer?
4. Have you lost a family member to breast cancer who had regular
mammography screenings?
5. Do you regularly perform a breast self-exam?
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6. Do you have a screening mammogram every year?
7. Have you had screening mammograms every year for the last 5 years?
8. Have you had an abnormal mammogram finding?
9. Did your doctor tell you that the result of your mammogram was not
conclusive?
10. Do you think a screening mammogram is the only available way to screen
women for breast cancer? Did you have an ultrasound ?
Each question had a choice of 5 responses that were based on a 5-point Likert
scale, as shown in Appendix F. The five response choices were: strongly agree, agree,
neither agree nor disagree, disagree, or strongly disagree. E-mail invitations were sent
between October 10-15, 2014. When respondent’s participation reached the saturation
point of 300 completed surveys, the participant field was closed. The online survey site
was accessible by user identification and a unique password, and I had sole access to the
completed surveys. I accessed the SurveyMonkey website and extracted the data. The
aim of the survey was to specifically to capture women that fit the required criteria and
the survey was formatted in such a way that prevented the participant to continue if the
specified criteria were not met. These inclusion criteria are shown in Consent Form A.
Qualitative
Advertisement flyers were placed at the Regional Medical Center breast care
center in Santa Clara County from November 3, 2014 to November 7, 2014 to recruit
participants. This center was chosen because of its dedicated breast imaging center that
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provide breast care services to a large community of women in Santa Clara County.
Those who wanted to participate in the study responded to me by e-mail. I responded
with Consent Form B (Appendix E), which specified they could withdraw from the study
at any time for any reason.
Data collection for the qualitative part of the study was conducted by telephone
from the first 10 respondents. The survey contained 5 open-ended questions as shown in
Appendix F:
1. Are you in the age group of 24 and 74 years? Do you perform routine
breast self-exams? Do you have a family history of breast cancer? Do you
have an annual mammogram? Do you have dense breast tissue based on a
mammogram? Were you told by her doctor that you needed a repeat
mammogram?
2. Have you had an ultrasound as a breast cancer screening? What was the
finding?
3. Did an MRI confirm your breast cancer diagnosis after the abnormal
mammogram finding?
4. Explain how you felt emotionally during the time it took for your doctor to
make a diagnosis for your breast cancer?
5. Do you believe that your breast cancer could have been detected earlier if
MRI was utilized after your initial cancer diagnosed accusing
mammograms?
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Participants were allowed a maximum of 5 minutes to respond to each question;
they were advised to set aside 30 minutes of uninterrupted time to complete the
interview. At the agreed time, I contacted each participant by telephone;all responses
were recorded by manual transcription. In addition, all interviewees were informed that
they might be asked to review the transcribed interview for accuracy.
There were no unusual circumstances to report for the quantitative and qualitative
data collection processes.
Data Analysis
The study employed a mixed methods explanatory approach (Creswell & Plano
Clark, 2008) and a qualitative approach. Table 1 below shows the tool used to collect
data, the scale used classify data collected and data analysis tool that were used for this
study.
Table 1
Data Analysis Tools
Data collection
Survey
Telephone interviews

Measurement scale
String/numeric
String

Data analysis tools
SPSS version 21
NVivo 10

Quantitative Data Analysis Using SPSS
Responses that were received from 300 respondents, based on a 5 point Likert
scale, were assigned a numeric code to match the actual participant response: 1= strongly
agree ; 2= agree;3 = neither agree nor disagree; 4=disagree ; and 5 = strongly disagree.
These values were entered to an Excel Spreadsheet and uploaded to a statistical software
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program Statistical Package for the Social Sciences (SPSS) version 21. A total of 3,000
Likert scale responses were imported from an Excel sspreadsheet into the data view
within the data editor of SPSS Version 2. Variables on the variable view of the data
editor were labeled age, good health, family history of breast cancer, lost a family
member to breast cancer, regular breast self-exams, annual screening mammogram,
screening mammograms for the last five years, abnormal mammogram finding, and result
of your mammogram abnormal. Importantly, on the variable view, each variable was
assigned a type. This selection allowed for all string values to convert to numeric values
in the data view of the data editor. The value label toggle selection in the data view
allowed switching between string and numeric data in the date editor in the SPSS
processor to allow numeric analysis of the total responses to each question. Two levels of
data analysis were calculated: descriptive statistics and the t test.
A descriptive statistical analysis of responses from N = 300 was done for all
queries to look at the distribution. SPSS produced an output statistical table that showed
descriptive statistics for the minimum and maximum of the scale, mean and standard
deviation of N = 300. The descriptive statistics table is shown in Appendix H. The sample
mean was not adequate to reject H0. Hence, the stem and lleaf plot analysis was done.
This analysis considered the entire sample, analyzed to display all variables, data value,
and their connection to other values such as confidence interval for mean, median,
variance standard deviation, and skewness. The stem and leaf analysis also revealed
whether there were problems with the distribution, such as extremes above and below the
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H0 that would stop the significance test. The stem and leaf analysis table is shown in
Appendix H.
The t test was the final computation for N = 300. The one-sample two-tailed t test
was employed to test the hypothesis for the research. The two-tailed t test was selected
because it can detect deviation on either side of H0. In the data view display within the
data editor of SPSS, the one sample t test was selected. All variables were analyzed with
a test value of 1. The test value 1 is not an arbitrary number and was selected because the
H0 =1. A one-sample sstatistics table and the one-sample test table were generated.
The one-sample sstatistics table, shown in Appendix J, displayed each variable
that tested N = 300: mmean, sstandard ddeviation and the sstandard eerror mean. The
importance of the one-sample sstatistics table is that it shows whether the correct sample
was analyzed. The one-sample test table provided the t statistic, df (degrees of freedom),
the significance (2-tailed) output, mean difference, and the confidence interval. Each
variable was analyzed to determine if H0 was rejected by this analysis.
The t statistic for each of the 10 items analyzed yielded values that range from 6.3
-104. Under H0, the t statistic = 0. This distribution placed the values for the t statistic
won the right tail of the distribution which means that H0 can be rejected.
The df, N-1 = 299, is standard for a one-sample t test. This is an important
variable in the analysis because df tells the software which t distribution to look at to
evaluate the t statistic.
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The significance reported a p value of 0.00. The two-tailed test was selected to
detect variations on either side of H0, as if there are deviations above or below the mean,
H0 can be rejected, hence the purpose of a two-tailed test. As suggested in Chapter 3, if
the p value has a value < 0.01, there is a possibility that the null hypothesis will be
rejected (Simon & Goes, 2013). The p value in this analysis wass < 0.01. Therefore, H0
was rejected. The research question as proposed by H0 in Chapter 3 that MRI for
screening women with DBT should be used as an adjunct to conventional mammography
was rejected.
The md of the analysis reported values from 0.173–3.4. This represents the
difference between the population and sample mean, as shown in Appendix I. If H0 was
true, md = 0. However md is not equal to zero, and H0 can be rejected.
The analysis reported a 95% cconfidence interval, (CI) with llower and uupper
bounds. The CI can be used to test H0. If the md =0, under H0 , 0 will not fall between the
llower and uupper bounds of CI, but will fall outside of the CI. This is evidence to reject
H0 at the .05 level of the CI. With a CI of 95%, the llower and upper bounds will capture
the true population mean, and in 5%, it will not.
As noted in Chapter 3, if the p value is < 0.01, will be rejected, H1 will be upheld
(Simon & Goes, 2013), and the investigation can continue to the second phase.
Qualitative Data Analysis Using NVivo
I transcribed telephone interviews with 10 participants and saved the data as a
Word document. Data were organized by assigning a number to each participant, 1-10.
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Ten word documents were created and named to match each participant and responses.
To ensure accuracy of the responses, I e-mailed the transcribed responses to each
participant and asked them to read their responses and check for accuracy.
Data were organized by numbers in NVivo 10 in the ssource workspace.
Questions and responses from each interview that were saved previously to a Word
document were imported and matched to the respective participant in the NVivo 10
workspace. When each participant was selected, the question and their responses were
displayed. As I examined responses to the five questions I asked each participant, 11
themes emerged. Each theme was created and entered into the node workspace of the
NVivo 10 program.
Question 1
Qualitative Research Question 2: “What are the lived experiences of women with
breast cancer in DBT prior to and after a breast cancer diagnosis?” To answer this
question participants were asked to respond to five questions (shown in Appendix F). The
first question had six sub-questions. Six themes emerged from their answers. Each theme
is discussed below.
Theme 1. Are you in the age group 25 through 75 years? Participants’ ages
ranged from 30 to 68. This age group is important for this investigation because younger
women typically have dense breast tissue as do pre and post-menopausal women (ACR,
2012).
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Theme 2. Do you perform routine breast self-exam? All participants responded
that they performed breast self-exam. Participant 1 responded that she found a lump in
her left breast during a self-exam. She was 68 years old, had had normal screening
mammograms since she was age 40, but in her 50s, there was a dense breast finding. She
had additional diagnostic imaging with a repeat mammogram and an ultrasound, but
these exams did not yield more information about her abnormal mammogram finding.
This is key to the study because their breast anomalies were missed with mammogram.
Even though Participant 1 followed all the rules and had annual screening for 10 years,
cancer had not been detected. The lump in her left breast was found when she did a breast
self-exams.
Theme 3. Do you have a family history of breast cancer? All participants
responded that there was no history of breast cancer. This was a criterion to participate in
the study as proposed in Chapter 1. The study examined the purposeful sample that did
not have a breast cancer history.
Theme 4. Do you have an annual mammogram? All participants responded
positively to this question. This response met the inclusion criteria for the study also. The
aim of this question is to find out if the outcome would be the same if these participants
did not have a screening mammogram.
Theme 5. Do you have dense breast tissue based on a mammogram? All
participants had a dense breast finding. The purpose of this question was to find out
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which diagnostic imaging technique was used to image this group and if the finding was
cancerous.
Theme 6. Were you told by your doctor that you needed a repeat mammogram?
Participants 1, 2, 3, 4, 9 and 10 had repeat mammograms and reported that the repeat
mammograms did not provide new information and that their doctors were not able to
provide clarity. Their doctors recommended an additional diagnostic test.
Question 2
Theme 7. Have you had an ultrasound as a breast cancer screening? Two
themes emerged from question2. Eighty percent of participants reported that an
uultrasound exam was recommended after the second mammogram because the results of
the screening and repeat mammograms were not conclusive. Participant 5 said her doctor
was very conservative, but she agreed to go through with more testing, as she was only
55 years old and was the breadwinner in her family.
Theme 8. What was the finding? Participants reported being relieved that their
physicians were not ignoring them and ordered more diagnostic tests to help make the
diagnosis. Participants 1, 2, and 4, said the ultrasound results were not conclusive;
Participants 3, 5, 6, and 7, said their ultrasound results said the area was too small, and
Participants 8, 9, and 10 stated that the ultrasound did not give more information. I
observed that these participants were well informed about dense breast findings and were
willing to have additional diagnostic tests to find the answer.
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Question 3
Theme 9. Did an MRI confirm your breast cancer diagnosis after the abnormal
mammogram finding? All participants expressed their dislike for the MRI scan. They
reported that test took about 45 minutes to one hour to complete but that it provided more
information that mammograms and ultrasound exams. The majority of participants said
that the results of the MRI reported breast cancer or suggested breast cancer.
Question 4
Theme 10. Explain how you felt emotionally during the time it took for your
doctor to make a diagnosis for your breast cancer? The purpose of this question was to
find out the emotional state of the women while they waited to schedule appointments for
additional tests so that physicians could make a diagnosis. The common concern for all
was the length of time they had to wait while they had repeated mammograms and
ultrasound exams. They were concerned that the cancer was not diagnosed early enough
or misdiagnosed and that they might not have enough time for treatment and recovery.
Some were concerned that they could possibility need a mastectomy. One of the common
concerns that all participants had was that there was too much time wasted on the repeat
mammogram and ultrasound exams.
Question 5
Theme 11. Do you believe that your breast cancer could have been detected
earlier if MRI was utilized after your initial cancer diagnosed using mammograms?

75

This question was included so I could learn whether participants were informed about
breast cancer in dense breast tissue and diagnostic imaging techniques that are available
for breast cancer screening. Most agreed that mammograms can miss anomalies in dense
breast tissue and that they were not pleased to repeat the mammogram because of
radiation. Additionally, more that 80 % of respondents said that the ultrasound did not
give additional information because the technique is not useful for dense breasts.
Although the MRI exam was very uncomfortable and look a long time, the majority of
participants said that it was the most accurate test that confirmed breast cancer. Major
themes are shown in Appendix K.
Evidence of Trustworthiness
This study fulfilled the construct validity by using the opinions from an expert
panel: a radiologist, a research scientist, and a physician. Each member sent feedback that
validated the content of the quantitative and qualitative survey tool. Member checking
was used to confirm the accuracy of my transcriptions. Each transcribed telephone
interview was sent to participants to review their answers to the interview questions. The
study could be replicated in another case by following my detailed records.
Summary
To learn the lived experiences of women with dense breast tissue and breast
cancer who had undergone tests for breast cancer, I conducted a qualitative study by
interviewing 10 women. Answers to five open-ended questions and responses from
interviews brought added clarity to the assertion that an adjunct imaging technique, in
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addition to conventional mammography, is needed to screen women with dense breast
tissue.
Chapter 5 will present an interpretation of the study, including limiting factors,
recommendations for future research, and how the results of the study might effect
positive social change.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
Breast cancer in DBT can go undetected with conventional screening methods
(Are You Dense? 2013), yet there are no directives in place for agencies and
organizations to screen women with DBT (ACR, 2013; ACS, 2012; CDC, 2013).
Women with DBT who are not predisposed to breast cancer and do not have a breast
cancer history are in the low-risk category and do not meet the standard for additional
breast cancer screening. Conventional breast screening is the only screening technique
that is used for this group; but using that technique alone can miss cancer in glandular
tissues. Although conventional mammography is effective for regular breast cancer
screening, this technique detects less than half of breast cancers in the population with
DBT (Are You Dense? 2013). A mixed-methods, sequential, explanatory approach was
used for this study because health studies are very complex, and it was believed that
adopting this approach could maximize the strengths of quantitative and qualitative data
collectively. The use of a single approach, quantitative or qualitative, would not have
been sufficient to answer the research questions.
This study was guided by two research questions: (a) Should MRI be used for
screening women with DBT as an adjunct to conventional mammography? and (b) What
are the lived experiences of women with breast cancer in DBT prior to and after the
breast cancer diagnosis? In this chapter, I will discuss the purpose of the study, present
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and interpret the findings, discuss limitations, and present the recommendations and
implications of the findings.
Purpose and Nature of the Study; Key Findings
The purpose of this mixed methods study was to explore, investigate and examine
to what extent mammograms and ultrasound techniques can miss cancer in women with
DBT. Consequently, I wanted to find out if the application of MRI techniques in the DBT
group might detect breast cancers that were undetected by mammogram and ultrasound. I
also wanted to learn about the journey that women with DBT experienced when they
found out that they had an abnormal finding and the process that they went through to get
the breast cancer diagnosis.
The first strand, the quantitative part of the study, was done to find out how many
abnormal findings there were in a random sample of 300 women. The second strand, the
qualitative part, was done to learn about lived experiences of women with DBT and the
journey they travelled to get to the cancer diagnosis. The purpose of the study was to add
information deduced from this study to existing literature about the need to add an
adjunct imaging technique to conventional screening methods to effectively screen
women with DBT. The proposed adjunct screening is the use of MRI techniques.
In a conventional screening of a random, healthy sample of 300 women N = 300,
with a DBT variable, 93% reported that they had abnormal breast findings. This analysis
was provided by the application of a mathematical computation called SPSS (Table 2).
This finding illuminates that there is a significant number of women with DBT. If there is
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such a significant population with abnormal breast findings and since mammograms and
ultrasound techniques can miss cancers with DBT (see the literature review for an
exhaustive review), then there is a need for a technique that has a higher sensitivity to
DBT.
Table 2
Abnormal Mammogram Findings 1
Scale
1
2
3
Valid
4
5
Total

Frequency Percent
40
13.3

Valid percent
13.3

Cumulative percent
13.3

240

80.0

80.0

93.3

3

1.0

1.0

94.3

12

4.0

4.0

98.3

5

1.7

1.7

100.0

300

100.0

100.0

Note: 93% of N=300 had an abnormal breast finding.
Findings from the qualitative portion revealed that women with DBT that do not
have a breast cancer history may undergo arduous breast screening processes before an
actual diagnosis. Repeat screening mammograms, diagnostic mammograms, and
ultrasound are additional tests this group has to undergo. The results were that some
women had screening reports with vague terminologies, findings that were inconclusive
or unclear and the message that additional test are needed. Data analysis using NVivo
concluded that 83% of the sample said they did not know the results of their screening
mammogram.
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Interpretation of the Findings
This study was based on two inquiries: Which breast imaging technique can
detect cancers in DBT and can be an adjunct to conventional mammography to screen for
breast cancer? Which imaging technique was utilized by a purposeful group of women
with DBT to get a breast cancer diagnosis? As discussed in Chapter 2, the ACR (2012)
reported that 80% of women have dense breast tissue, and Berg (2009) reported that
conventional mammography which is the standard to screen for breast cancer can miss
cancers that are in these tissues. This study revealed that more than 90% of N = 300 had
an abnormal mammogram finding. Table 3 shown below shows that from a random
sample of 300 participants, 280 women had an abnormal mammogram result.
Table 3
Abnormal Mammogram Findings 2
Frequency Percent
Valid Percent Cumulative Percent
1
40
13.3
13.3
2
240
80.0
80.0
3
3
1.0
1.0
Valid
4
12
4.0
4.0
5
5
1.7
1.7
Total
300
100.0
100.0

13.3
93.3
94.3
98.3
100.0

This finding confirmed that a significant population of women has DBT and an
abnormal mammogram. In addition, these findings suggest that there is a need for an
adjunct screening method for women with DBT because conventional mammogram can
miss anomalies in this kind of tissue (Berg, 2009). In Chapter 2, the ACS (2012) stated
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that DBT is not a significant finding for women that are in the asymptomatic category,
but data collected for this study revealed that women with DBT that had MRI, that
confirmed breast cancer.
Qualitative data revealed that a significant number women that participated in the
study in the age group 24–74, with dense breast tissue, without family history of cancer,
and had annual screening mammograms, had breast cancer that was undetected. These
women had breast screening with conventional mammogram and ultrasound. More than
50% of these women had repeat mammograms, diagnostic mammograms, and ultrasound
exams. Results from these exams were “non-conclusive,” “not clear,” or “more tests were
needed.” All women had an MRI report of positive results. MRI has a high specificity to
detect anomalies and cancers in granular tissues (Frank, 2011).
Limitations of the Study
One limitation is that e-mail surveys came only from residents of Santa Clara
County, limiting the population to a small geographic area that may not be typical of
women in general. Although statistics indicate that people are highly inclined to respond
honestly to a survey like this, there is no way to determine if the questions asked were
answered truthfully.
Ultrasound can also produce false positive results (Berg, 2008) due to the lack of
proficiency of operators and lack of standardized protocols. Berg (2008) also suggested
that the quality of an ultrasound depends on the skill of the operator. All participants had
an ultrasound after the screening mammogram. There was no way to measure the skill of
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the technologist or know what protocols were used. MRI can also produce false positive
results. Descriptive statistics collected from the 20% of the women who participated in
the qualitative part of the study showed they had breast biopsies to confirm breast cancer.
The reason for a biopsy was unclear.
After I had 10 positive responses, I stopped recruiting participants. These were all
patients of one breast cancer center. There was no way to tell if the sample was slightly
larger than 10 and what descriptive data might yield from a larger sample. It is also not
clear if these results can be applied to the general population.
The weight of the methodology possibly weighed slightly heavily towards the
quantitative than qualitative data.
The final limitation for the study could be the right point in data collection to mix
results of collection, analysis, or interpretation (Creswell, 2009). Quantitative data were
analyzed first.
Recommendations
The findings of this study prompted several recommendations. That health
organizations and agencies set a standard that MRI screening should be used with
conventional mammograms to screen women with DBT for breast cancer because of its
high sensitivity to DBT (Berg, 2009; Frank, 2011). Health care providers, however,
should be aware of the significant number of women that are diagnosed with DBT
(ACR, 2012), and are positive for breast cancer, even though they do not have a family
history of cancer. MRI is an effective screening method to detect cancers in DBT and
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organizations should add this technique to conventional mammogram to screen for breast
cancer.
The mixed methods sequential explanatory approach was the most appropriate for
this type of health investigation as it strengthened the robustness of the quantitative and
qualitative strands (Creswell, 2009). The quantitative paradigm guided data collection
and analysis, while the qualitative design guided the in-depth interviews and data
analysis. Quantitative data were used to test H0 and explore the determination that more
thorough and complete data are needed to determine without question that an adjunct
imaging method is needed to screen women with dense breast tissue.
Further research is needed to screen various groups of women with DBT, to
compare the combination of the effectiveness or not of mammograms and ultrasound
versus mammograms and MRI techniques. In addition, there was a low participation
response for the women 25–50 for this study; therefore, the outcome for this group could
not be measured.
Implications
Breast cancer, with a high mortality in the United States, is the second-most
deadly disease in women (NCI, 2012). But if it is detected in an early stage, it can be
treated effectively, and a positive prognosis is more likely. If MRI is used as an adjunct to
conventional mammograms, accurate breast cancer results may be produced, a condition
that might lead to a rapid breast cancer diagnosis, potentially lowering mortality rates for
this group of women and bringing about the social change of reduced preventable early
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death. This is not to diminish the importance of breast self-examination and annual
mammography screening processes that continue to be highly recommended.
Conclusion
Early detection of breast cancer can result in earlier treatment and decreased
mortality rates for women with DBT. Imaging of DBT utilizing MRI has yielded accurate
findings for breast cancer among the group of women with DBT and a lower number of
false positive cases. MRI has a higher sensitivity for imaging DBT because it has unique
characteristics to see inside dense tissues. If MRI is added to conventional
mammography, there should be a higher diagnosis rate for breast cancer, and the disease
can be treated in the early stages. Utilizing MRI to image women with DBT would bring
social change to the individual, families of women with DBT, and the breast cancer
community.
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Appendix A: Cover Letter to Expert Panelists
Dear Potential Participant,
I am a doctoral student in the Walden University Health Services program. The
university has approved my request to conduct research by granting me IRB approval
number 10-07-14-0078441 to conduct this study. The reason for the survey is to fulfill
the university’s requirement for the PhD and to request your expert opinion on the
following question: Can or should MRI techniques be used with conventional
mammograms to screen women with dense breast tissue for breast cancer?
If you would like to participate in the study, please complete the enclosed sixquestion survey. The anticipated time to complete this survey is no longer than 15
minutes, and the results will be used to support a larger study. After you complete the
survey, please used the stamped, self-addressed envelope and mail your response within 7
days. Your identity and responses will be kept confidential. If you are interested in
participating, please send an e-mail to rachel.connett@waldenu.edu.
Thank you for participating.
Rachel Connett
PhD Candidate
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Appendix B: Cover Letter to Participants for Quantitative Data Collection
Dear Participant,
I am a Ph.D. graduate student with Walden University, Health Services program
and I am covered by IRB Approval # 10-07-14-0078441 to conduct this study. This
purpose of this study is to determine if MRI techniques can be used along with
conventional mammograms to screen women with dense breast tissue for breast cancer
detection. The primary reason of the study is to fulfill the university’s requirement for the
student to gain her Ph.D.
The survey will be done by an online survey company called SurveyMonkey. If
you choose to participant in this study, you will be sent login information to access the
website. The survey will have 11 questions with five options for your response. The
survey should take about 30 minutes to complete. Your personal information will not be
used and your responses will be kept confidential. If you would like to participate in the
study, please send an e-mail to rachel.connett@waldenu.edu.

Thank you for your participation,
Signature
Rachel Connett
Ph.D. Candidate
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Appendix C: Cover Letter to Participants for Qualitative Data Collection
Dear Participant,
I am a Ph.D. graduate student with Walden University, Health Services program
and I am covered by IRB Approval # 10-07-14-0078441 to conduct this study. This
purpose of this study is to determine if MRI techniques can be used along with
conventional mammograms to screen women with dense breast tissue for breast cancer
detection. The primary reason of the study is to fulfill the university’s requirement for the
student to gain her Ph.D.
The survey will be done by the researcher through telephone interviews to collect
responses to 5 questions. Each question will be given a response time of 3 to 5 minutes.
The entire survey will take about 30 minutes to complete.
Your personal information will not be used and your responses will be kept
confidential. If you would like to participate in the study, please send an e-mail to
rrachel.connett@waldenu.edu.

Thank you for your participation,
Signature
Rachel Connett
Ph.D. Candidate
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Appendix E: Telephone Script for Researcher
Hello Ms. Doe, thanks for taking the time to speak with me. My name is Rachel
Connett, and I am a Ph. D. student and researcher with Walden University. I would like
to understand the process from the time you began breast cancer screening until now as it
is relevant to the different screening imaging techniques that were used to image dense
breast tissue. Your feedback will help me to understand which technique, ultrasound or
MRI, is more effective to use with conventional mammogram for breast cancer detection
in dense breast tissue. The information gathered will help women with dense breasts and
the dense breast cancer community make an informed decision about the most effective
imaging option they can make when they are presented with a dense breast diagnosis.
Your participation in this interview and your responses will remain confidential.
Thank you for your participation,
Rachel Connett
Ph.D. Candidate
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Appendix F: Research Study Questions for the Expert Panel
How many years of experience have you had in interpreting screening mammographic
images?
How many years of experience have you had in interpreting MRI images for breast
cancer?
Was there a high percentage for repeat mammograms due to glandular breast tissue with
conventional mammogram?
Elaborate on conventional mammogram and ultrasound as screening methods for dense
breast tissue.
Does MRI have a higher specificity for dense breast tissue?
Does MRI of glandular tissues yield more findings for breast cancer?
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Questionnaire for Quantitative Participants
1. Is your age between 24 and 74 years?
2. Are you in good health?
3. Do you have a family history of breast cancer?
4. Have you lost a family member to breast cancer who had regular mammography
screenings?
5. Do you regularly perform a breast self-exam?
6. Do you have a screening mammogram every year?
7. Have you had screening mammograms every year for the last five years?
8. Have you had an abnormal mammogram finding?
9. Did your doctor tell you that the result of your mammogram was not conclusive?
10. Do you think a screening mammogram is the only available way to screen women
for breast cancer and did you have an ultrasound ?
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Likert scale:
Strongly agree =1

Agree=2

Neither=3

Disagree=4

Survey questions
Item
Is your age between 24 and 74 years?
Are you in good health?
Do you have a family history of breast
cancer?
Have you lost a family member to breast
cancer?
Do you regularly perform a breast selfexam?
Do you have a screening mammogram
every year?
Have you had screening mammograms
every year for the last five years
Have you had an abnormal mammogram
finding
Did your doctor tell you that the result of
your mammogram
Do you think a screening mammogram is
the only available way to screen women for
breast cancer and did you have an
ultrasound

strongly disagree=5
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Questionnaire for Qualitative Participants:
1. Are you in the age group of 24 to 74 years?
2. Do you perform routine breast self-exams?
3. Do you have a family history of breast cancer?
4. Do you have an annual mammogram?
5. Do you have dense breast tissue based on a mammogram?
6. Were you told by her doctor that you needed a repeat mammogram?
7. Have you had an ultrasound as a breast cancer screening?
8. What was the finding?
9. Did an MRI confirm your breast cancer diagnosis after the abnormal
mammogram finding?
10. Explain how you felt emotionally during the time it took for your doctor to
make a diagnosis for your breast cancer.
Do you believe that your breast cancer could have been detected earlier if MRI
was utilized after your initial cancer diagnosed using mammograms
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Appendix G: Expert Panelists
Dr. Jafi Jipson, MD (Radiologist)
Dr. Thomas Huang, MD (Clinician)
Dr. Ann Shimakawa PhD (Research Scientist)
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Appendix H: Descriptives
N

Minimum

Maximum

Mean

Std. Deviation

Age

300

1

5

1.17

.473

Good health

300

1

5

1.63

.594

Family history of breast cancer

300

1

5

4.40

.567

Lost a family member to breast cancer

300

1

5

4.40

1.085

Regularly self-breast exam

300

1

5

1.92

.456

Screening mammogram every year

300

1

5

1.69

.572

Screening mammograms every year for the

300

1

5

2.84

1.570

Abnormal mammogram finding

300

1

5

2.01

.674

Result of your mammogram abnormal

300

1

5

4.12

1.296

Ultrasound after the screening mammogram

300

1

5

1.97

.767

Valid N (listwise)

300

last five
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Appendix I: t Test One-Sample Statistics

N

Mean

Std. deviation

Std. error
mean

Age

300

1.17

.473

.027

Good health

300

1.63

.594

.034

Family history of breast cancer

300

4.40

.567

.033

Lost a family member to breast cancer

300

4.40

1.085

.063

Regularly self-breast exam

300

1.92

.456

.026

Screening mammogram every year

300

1.69

.572

.033

Screening mammo every year for the last 5

300

2.84

1.570

.091

Abnormal mammogram finding

300

2.01

.674

.039

Result of your mammogram abnormal

300

4.12

1.296

.075

Ultrasound after the screening mammogram

300

1.97

.767

.044

years
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Appendix J: One-Sample t Test

t

df

Variable

Age
Good health
Family history of breast cancer
Lost a family member to breast
cancer
Regularly self-breast exam
Screening mammogram every
year
Screening mammograms every
year for the last five
Abnormal mammogram finding
Result of your mammogram
abnormal
Ultrasound after the screening
mammogram

Test value = 1
Sig. (2Mean
tailed) difference

95% confidence
interval
of the difference
Lower Upper

6.343
18.453
103.930
54.238

299
299
299
299

.000
.000
.000
.000

.173
.633
3.400
3.397

.12
.57
3.34
3.27

.23
.70
3.46
3.52

34.971
20.999

299
299

.000
.000

.920
.693

.87
.63

.97
.76

20.263

299

.000

1.837

1.66

2.02

25.854
41.732

299
299

.000
.000

1.007
3.123

.93
2.98

1.08
3.27

21.987

299

.000

.973

.89

1.06
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Appendix K: Major Themes
Participants Age Health Status Annual Screen Repeat Mammo US exam Abnormal
MRI
P1
P2
P3
P4
P5
P6
P7
P8
P9
P10
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Appendix L: Letters of Cooperation:
1. SEER
2. CCR
3. RMC
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129
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Appendix O: Responses from Qualitative Interviews
Participant 1:
1. Are you in the age group 24 to 74 years? Yes, I am 68 years old.
2. Do you perform routine breast self-exams? Yes, I do. That is how I found the lump
in my left breast.
3. Do you have a family history of breast cancer? No, my family does not have breast
cancer.
4. Do you have an annual mammogram? I have always had an annual mammogram,
since I was in my 40s.
5. Do you have dense breast tissue based on a mammogram? Yes. I think I was in my
50s when my doctor told me I had “granular breast tissue.” He said there were areas
in my left breast that he could see through.
6. Were you told by your doctor that you needed a repeat mammogram? Yes, I had a
repeat mammogram, which did not give more information than the previous one.
7. Have you had an ultrasound as a breast cancer screening? An ultrasound exam was
recommended. What was the finding? Not much different that the two mammograms
that I had. My doctor recommended that if I am okay with it, that an MRI can be
done to get more information, and a biopsy of the area can be done to get more
information.
8. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram
finding? The uultrasound exam did not give new information, but the MRI did. The
MRI was very uncomfortable: I was given an injection and had to lie on my chest for
about 45 minutes. Then the doctor took a sample of my breast tissue and sent it to
the lab. Thankfully, the area in question was very small and was taken out. I had
radiation to kill any cancer cells that were there after the surgery.
9. Explain how you felt emotionally during the time it took for your doctor to make a
diagnosis for your breast cancer? It was very scary and nerve racking to wait for the
results. I was upset because for so long I took good care of my health: annual
physicals, blood tests, mammograms, and now, breast cancer. The good news is that
the cancer did not spread, and my lymph nodes are ok. Now, all I have is an MRI
every year, just to check for change.
10. Do you believe that your breast cancer could have been detected earlier if MRI was
utilized after your initial cancer diagnosed using mammograms? I think so. It seems
like I was not diagnosed properly or misdiagnosed, and I wasted my time with the
ultrasound especially, which was a waste of time. The MRI is not easy, but my
doctor told me it is the best exam for my checkups.
Participant #2
1. Are you in the age group of 24 to 74 years? I am 60 years old
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2. Do you perform routine breast self-exams? Yes, since my children were born.
3. Do you have a family history of breast cancer? No, neither side of my family. We
have other things though: diabetes.
4. Do you have an annual mammogram? Every year since I was 40.
5. Do you have dense breast tissue based on a mammogram? Yes, my mammograms
were clear until last year.
6. Were you told by her doctor that you needed a repeat mammogram? Yes, my doctor
ordered a diagnostic mammogram. At first, they diagnosed the areas as calcium, but
continued to order more tests. Have you had an ultrasound as a breast cancer
screening? I had an ultrasound exam which did not do much good, and the doctor
said it looked suspicious. My doctor said it would be best to do more tests. He wrote
a script for an MRI.
7. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram
finding? It was the most awful exam I ever had. It took so long. They made me lie on
my chest, for a very long time. Then, the doctor took a tissue sample. My doctor’s
office called me to come in to talk about the results. The results came back positive
for cancer.
8. Explain how you felt emotionally during the time it took for your doctor to make a
diagnosis for your breast cancer? I was very scared. The time to wait for the results
was almost two weeks.
9. Do you believe that your breast cancer could have been detected earlier if MRI was
utilized after your initial cancer diagnosed using mammograms?
10. I do not get it. How did the mammogram miss the cancer? I have so many questions
about this. Needless to say, my annual breast screen is done with MRI only.
Participant #3
1. Are you in the age group of 24 to 74 years? I am 55 years old.
2. Do you perform routine breast self-exams? Yes I do, every month.
3. Do you have a family history of breast cancer? No family history, both sides.
4. Do you have an annual mammogram? Yes, since age 40.
5. Do you have dense breast tissue based on a mammogram? Yes. When I turned 50,
my mammogram result was not conclusive and I had to do a repeat mammogram
because my breast tissue was dense.
Were you told by your doctor that you needed a repeat mammogram?
6. I had a repeat mammogram. The technician said they needed more close up shots of
the dense areas.
7. Have you had an ultrasound as a breast cancer screening? I had an Ultrasound exam
after the second mammogram. My doctor said the area was too small to diagnose, so
I had an MRI exam.
8. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram
finding? Yes, the MRI and some kind of special software helped the doctor to figure

132

it out. Thank God, the area that they were not sure about was small, and the tumor
was taken out.
9. Explain how you felt emotionally during the time it took for your doctor to make a
diagnosis for your breast cancer? I was totally scared. I have 2 children, both in
college, and was scared of what I did not know.
10. Do you believe that your breast cancer could have been detected earlier if MRI was
utilized after your initial cancer diagnosed using mammograms? Absolutely. Not
sure why the MRI was not done after the first mammogram. Since my diagnosis, I
always get an MRI for my checkup.
Response from Participant #4:
1.
2.
3.
4.
5.

Are you in the age group of 24 to 74 years? I am 45
Do you perform routine breast self-exams? Yes. I am a nurse.
Do you have a family history of breast cancer? No.
Do you have an annual mammogram? Yes, since I was 35 years old
Do you have dense breast tissue based on a mammogram? Yes, and my doctor told
me it was ok, not to worry.
Were you told by her doctor that you needed a repeat mammogram? Two years ago,
my mammogram result was BI-RADS 4.
6. Have you had an ultrasound as a breast cancer screening? Yes, and my doctor said
he was not satisfied because the test did not give more information that the first
mammogram
7. What was the finding? Inconclusive.
8. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram
finding? Yes. The mammogram and ultrasound were both inconclusive.
9. Explain how you felt emotionally during the time it took for your doctor to make a
diagnosis for your breast cancer? I thought I was taking good care of myself when I
started breast cancer screening at age 35. It was very frustrating to know that the
mammogram did not detect the cancer earlier.
10. Do you believe that your breast cancer could have been detected earlier if MRI was
utilized after your initial cancer diagnosed using mammograms? Yes. I believe that
the mammogram was ok, but the Ultrasound was useless, and that an MRI should
have been ordered after the mammogram.
Response from Participant #5:
1.
2.
3.
4.
5.

Are you in the age group of 24 to 74 years? 55 years.
Do you perform routine breast self-exams? Yes
Do you have a family history of breast cancer? No.
Do you have an annual mammogram? Yes, since I was 40.
Do you have dense breast tissue based on a mammogram? Yes. When I was 45.
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Were you told by her doctor that you needed a repeat mammogram? Yes. My doctor
said my mammogram was not clear because of the dense tissue.
6. Have you had an ultrasound as a breast cancer screening? Yes, after the second
mammogram.
7. What was the finding? Not much else that the mammogram which was BI-RAD4.
8. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram
finding? The MRI was a horrible test. I had to lay to lay on my chest for over one
hour. The biopsy came back positive for breast cancer.
9. Explain how you felt emotionally during the time it took for your doctor to make a
diagnosis for your breast cancer? The wait was the worst part. My family and I
suffered because it took over one week to get the results. We kind of kneww after
the tests that something was not right.
10. Do you believe that your breast cancer could have been detected earlier if MRI was
utilized after your initial cancer diagnosed using mammograms? Yes. If the MRI
was done right after the first mammogram. I would have known the results and
would have had the conversation with my doctor.
Response from Participant #6:
1. Are you in the age group of 24 to 74 years? I am 49.
2. Do you perform routine breast self-exams? Yes, all the time.
3. Do you have a family history of breast cancer? No cancer in the family, both sides
are clear.
4. Do you have an annual mammogram? Yes, since I was 40.
5. Do you have dense breast tissue based on a mammogram? Yes. When I was 45, my
mammogram came back with a BI-RADS4. The doctor explained that this number
was too high and that I needed more tests.
Were you told by her doctor that you needed a repeat mammogram? Yes, I had a
diagnostic mammogram.
6. Have you had an ultrasound as a breast cancer screening? An Ultrasound exam was
recommended.
7. What was the finding? The report said inconclusive, but suggest that there could be
cancer.
8. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram
finding? Yes. Although the MRI was a hard test, they took a breast tissue after the
MRI and sent it to the lab.
9. Explain how you felt emotionally during the time it took for your doctor to make a
diagnosis for your breast cancer? It took several weeks to get all the tests and the lab
work done. The wait was terrible because I did not know.
10. Do you believe that your breast cancer could have been detected earlier if MRI was
utilized after your initial cancer diagnosed using mammograms? Yes. If the MRI
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was done after the first mammogram, I would have need so devastated. The
ultrasound did not find much.
Response from Participant #7:
1.
2.
3.
4.
5.

Are you in the age group of 24 to 74 years? I am 48 years old.
Do you perform routine breast self-exams? Yes
Do you have a family history of breast cancer? No.
Do you have an annual mammogram? Yes, since I was 40 years old
Do you have dense breast tissue based on a mammogram? Yes, dense breast tissue
was the finding three years ago.
Were you told by her doctor that you needed a repeat mammogram? Yes. My
mammograms were normal, but when I was 45, I had the bad news that I had to do
more tests because there was an area in my left breast that was suspicious.
6. Have you had an ultrasound as a breast cancer screening? Yes, an Ultrasound exam
was recommended after the last mammogram.
7. What was the finding? Inconclusive, because the area was too small for the
ultrasound exam.
8. Did an MRI confirm your breast cancer diagnosis after the abnormal mammogram
finding? Yes, after both the mammogram and ultrasound exams and a biopsy, the
result was cancer.
9. Explain how you felt emotionally during the time it took for your doctor to make a
diagnosis for your breast cancer? It took a toll on my health that something was
wrong. I was a basket case. My family was affected so much because I have small
children and I wanted to be around to take care of them. I was too young to die.
10. Do you believe that your breast cancer could have been detected earlier if MRI was
utilized after your initial cancer diagnosed using mammograms? Yes. I still do not
understand how my mammograms were normal for five years and suddenly became
abnormal. My doctor should have ordered an MRI sooner.
Response from Participant #8:
1.
2.
3.
4.
5.

Are you in the age group of 25 and 75 years? I am 57 years old
Do you perform routine breast self-exams? Yes, every month.
Do you have a family history of breast cancer? No history, thank God.
Do you have an annual mammogram? Yes, since I was 40.
Do you have dense breast tissue based on a mammogram? Yes. When I turned 50,
my mammogram result changes from normal to dense.
Were you told by her doctor that you needed a repeat mammogram? Yes, I had
repeat test.
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6. Have you had an ultrasound as a breast cancer screening? After the repeat
mammogram, my doctor was not convinced with the results and said an
ultrasound exam was needed.
7. What was the finding? My doctor said he was not convinced that the ultrasound
gave better results.
8. Did an MRI confirm your breast cancer diagnosis after the abnormal
mammogram finding? I had an MRI and a biopsy that confirmed that the breast
tissue was cancerous.
9. Explain how you felt emotionally during the time it took for your doctor to make
a diagnosis for your breast cancer? I waited almost one month to get approval and
appointments to get all the tests done. It was mentally draining to know something
was wrong, but did not know what.
10. Do you believe that your breast cancer could have been detected earlier if MRI
was utilized after your initial cancer diagnosed using mammograms? Yes, if the
MRI was done after the first abnormal mammogram result, the stress would have
been lessened for me and my family. The ultrasound did not find much.
Response from Participant #9:
1.
2.
3.
4.
5.

6.
7.
8.

9.

Are you in the age group of 24 to 74 years? I am 57 years old.
Do you perform routine breast self-exams? Yes, religiously.
Do you have a family history of breast cancer? None.
Do you have an annual mammogram? Every year since I was 40.
Do you have dense breast tissue based on a mammogram? Not at first, but as I got
older. I believe when I was 52, that was five years ago. I do not understand this.
What in my body changed?
Were you told by her doctor that you needed a repeat mammogram? Yes, I had a
follow up repeat mammogram, where I had zoomed in pictures. I had BI-RADS4
result.
Have you had an ultrasound as a breast cancer screening? Yes. The BI-RADS 4
prompted more testing. My doctor recommended an ultrasound exam.
What was the finding? Not much more than the mammogram. And my doctor
ordered an MRI test.
Did an MRI confirm your breast cancer diagnosis after the abnormal
mammogram finding? Yes. Although the MRI test was very hard for me to do, as
I have problems with small spaces, I managed to finish the exam. The doctor took
a tissue sample and sent it to the lab. The exam suggested breast cancer.
Explain how you felt emotionally during the time it took for your doctor to make
a diagnosis for your breast cancer? Very scared and devastateded. I felt like the
doctors took too long and did tests that were not needed.
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10. Do you believe that your breast cancer could have been detected earlier if MRI
was utilized after your initial cancer diagnosed using mammograms? Yes. I
believe that the second exam should have needed an MRI.
Response from Participant #10:
1. Are you in the age group of 24 to 74 years? I am 30 years old.
2. Do you perform routine breast self-exams? Yes, that is when found a lump. I had
a sore area, and when I pressed on it, it was painful.
3. Do you have a family history of breast cancer? Not at all
4. Do you have an annual mammogram? Since I was 25 years old.
5. Do you have dense breast tissue based on a mammogram? Yes. When I felt the
lump, I made an appointment with my GP, and she wrote a script for a
mammogram.
Were you told by her doctor that you needed a repeat mammogram? I had to
repeat the mammogram because I have dense tissue, and the mammogram was
not able to see through the tissue and I was still having pain in my right breast.
6. Have you had an ultrasound as a breast cancer screening? The radiologist
recommended an ultrasound exam.
7. What was the finding? Very technical jargon…but not conclusive. And I was still
having pain.
8. Did an MRI confirm your breast cancer diagnosis after the abnormal
mammogram finding? The MRI showed that I had a small area that was
suspicious for cancer and I had a biopsy which showed cancer cells.
9. Explain how you felt emotionally during the time it took for your doctor to make
a diagnosis for your breast cancer? It was nerve racking. I have no cancer history
on both sides of my family, which puzzled my doctors.
10. Do you believe that your breast cancer could have been detected earlier if MRI
was utilized after your initial cancer diagnosed using mammograms? Yes, and a
biopsy were done at the same time. The time it took to get in to do the tests was
long. It seemed that my test was not urgent enough. If the MRI was done early, I
would not be so stressed.

